US20050209512A1 - Detecting sleep - Google Patents

Detecting sleep Download PDF

Info

Publication number
US20050209512A1
US20050209512A1 US10/825,964 US82596404A US2005209512A1 US 20050209512 A1 US20050209512 A1 US 20050209512A1 US 82596404 A US82596404 A US 82596404A US 2005209512 A1 US2005209512 A1 US 2005209512A1
Authority
US
United States
Prior art keywords
patient
value
sleep
asleep
processor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/825,964
Inventor
Kenneth Heruth
Keith Miesel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority to US10/825,964 priority Critical patent/US20050209512A1/en
Assigned to MEDTRONIC, INC. reassignment MEDTRONIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HERUTH, KENNETH T., MIESEL, KEITH A.
Priority to PCT/US2005/008881 priority patent/WO2005089641A1/en
Priority to DE602005020758T priority patent/DE602005020758D1/en
Priority to AT05725806T priority patent/ATE464836T1/en
Priority to EP05725806A priority patent/EP1732436B1/en
Priority to US11/081,786 priority patent/US7775993B2/en
Publication of US20050209512A1 publication Critical patent/US20050209512A1/en
Priority to US11/691,405 priority patent/US8055348B2/en
Priority to US12/828,981 priority patent/US20100274106A1/en
Priority to US13/249,862 priority patent/US8332038B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4809Sleep detection, i.e. determining whether a subject is asleep or not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36078Inducing or controlling sleep or relaxation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36135Control systems using physiological parameters
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/08Other bio-electrical signals
    • A61M2230/10Electroencephalographic signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/62Posture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/63Motion, e.g. physical activity

Definitions

  • the invention relates to medical devices, and to techniques for determining whether a patient is asleep.
  • the ability to determine whether a patient is asleep is useful in a variety of medical contexts. In some situations, the ability to determine whether a patient is asleep is used to diagnose conditions of the patient. For example, the amount of time that patients sleep, the extent of arousals during sleep, and the times of day that patients sleep have been used to diagnose sleep apnea. Such sleep information could also be used to diagnose psychological disorders, such as depression and mania.
  • a determination as to whether a patient is asleep is used to control delivery of therapy to the patient.
  • neurostimulation or drug therapies can be suspended when the patient is asleep, or the intensity/dosage of the therapies can be reduced when a patient is asleep.
  • the rate response settings of a cardiac pacemaker may be adjusted to less aggressive settings when the patient is asleep so that the patient's heart will not be paced at an inappropriately high rate during sleep.
  • therapy may be suspended or adjusted when the patient is asleep to avoid patient discomfort, or to conserve a battery and/or contents of a fluid reservoir of an implantable medical device when the therapy may be unneeded or ineffective.
  • a therapy intended to be delivered when the patient is asleep such as therapy intended to prevent or treat sleep apnea, is delivered based on a determination that the patient is asleep.
  • EEG electroencephalogram
  • Existing techniques for determining whether a patient is asleep include monitoring the electroencephalogram (EEG) of the patient to identify brain wave activity indicative of sleep.
  • EEG monitoring typically requires that an array of electrodes be placed on a patient's scalp and coupled to an external monitoring device, and is most often performed in a clinic setting.
  • an implantable medical device may only be used to monitor a patient's EEG in the rare cases when it is coupled to electrodes implanted within the brain of the patient. Consequently, EEG monitoring is generally unsuitable as a technique for determining whether a patient is asleep in order to control therapy, or for long-term monitoring of the patient's sleep/wake cycle.
  • Existing techniques employed by implantable medical devices to determine whether a patient is asleep include monitoring the patient's respiration rate, respiration rate variability, and activity level. Each of these physiological parameters may be an inaccurate indicator of whether a patient is asleep. For example, from the perspective of these physiological parameters, it may appear that a patient is sleeping when, instead, the patient is merely lying down in a relaxed state. As another example, respiration rate and respiration rate variability, for example, may fail to accurately indicate that the patient is asleep when the patient suffers from a breathing disorder, such as Cheyne-Stokes syndrome.
  • the invention is directed to techniques for determining whether a patient is asleep.
  • the invention is directed to techniques that involve determination of values of one or more sleep metrics that indicate a probability of a patient being asleep based on the current value of one or more physiological parameters of the patient.
  • Use of a plurality of sleep metrics, in particular, may allow for a more accurate determination of whether a patient is asleep.
  • a system includes one or more sensors and a processor.
  • Each of the sensors generates a signal as a function of at least one physiological parameter of a patient that may discernibly change when the patient is asleep.
  • physiological parameters include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, arterial blood flow, and galvanic skin response.
  • the processor monitors the physiological parameters based on the signals generated by the sensors, and determines whether the patient is asleep based on values for the physiological parameters.
  • the value for a physiological parameter may be a current, mean or median value for the parameter.
  • the processor may additionally or alternatively determine whether the patient is asleep based on the variability of one or more of the physiological parameters.
  • the processor determines a value of a sleep metric that indicates a probability of the patient being asleep based on a physiological parameter.
  • the processor may apply a function or look-up table to the current value and/or variability of the physiological parameter to determine the sleep metric value.
  • the processor may compare the sleep metric value to a threshold value to determine whether the patient is asleep.
  • the processor may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of the patient, e.g., rapid eye movement (REM), or one of the nonrapid eye movement (NREM) states (S 1 , S 2 , S 3 , S 4 ). Because they provide the most “refreshing” type of sleep, the ability to determine whether the patient is in one of the S 3 and S 4 sleep states may be, in some embodiments, particularly useful.
  • REM rapid eye movement
  • NREM nonrapid eye movement
  • the processor may determine a sleep metric value for each of a plurality of physiological parameters.
  • the processor may apply a function or look-up table for each parameter to the current value for that parameter in order to determine the sleep metric value for that parameter.
  • the processor may average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value for comparison to the threshold values.
  • a weighting factor may be applied to one or more of the sleep metric values.
  • One or more of functions, look-up tables, thresholds and weighting factors may be selected or adjusted by a user in order to select or adjust the sensitivity and specificity of the system in determining whether the patient is asleep.
  • the processor is included as part of a medical device, such as an implantable medical device.
  • the sensors may also be included within the medical device, coupled to the medical device by one or more leads, or in wireless communication with the medical device.
  • the medical device may control delivery of therapy to the patient based on the determination as to whether the patient is asleep, or may store information indicating when the patient is asleep for later retrieval and analysis by user.
  • the medical device may instead use the one or more sleep metric values to control delivery of therapy, or may store one or more sleep metric values.
  • information relating to the patient's sleep patterns may be used to diagnose sleep or psychological disorder, or may be used to evaluate the effectiveness of a therapy delivered to the patient.
  • the invention is directed to a method in which a plurality of physiological parameters of a patient are monitored and a value of a sleep metric that indicates a probability of the patient being asleep is determined based on the physiological parameters.
  • the invention is directed to a medical system that comprises at least one sensor and a processor.
  • the sensor generates a signal as a function of at least one physiological parameter of a patient.
  • the processor receives the signal from the sensor, monitors a plurality of physiological parameters of the patient, and determines a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • the invention is directed to a medical system that comprises means for monitoring a plurality of physiological parameters of a patient and means for determining a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • the invention is directed to a method in which a physiological parameter of a patient is monitored via an implantable medical device, and whether the patient is asleep is determined based on the physiological parameter.
  • the physiological parameter comprises one of heart rate, blood pressure, blood oxygen saturation, muscular activity and core temperature.
  • the invention is directed to a medical system that comprises a sensor and an implantable medical device.
  • the sensor generates a signal as a function of a physiological parameter of a patient.
  • the physiological parameter comprises one of heart rate, blood pressure, blood oxygen saturation, muscular activity, core temperature, arterial blood flow, and galvanic skin response.
  • the implantable medical device includes a processor that monitors the physiological parameter based on the signal and determines whether the patient is asleep based on the physiological parameter.
  • the invention is directed to a computer-readable medium comprising program instructions.
  • the instructions cause a programmable processor to monitor a plurality of physiological parameters of a patient, and determine a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • the invention may be capable of providing one or more advantages.
  • the invention provides techniques for determining a sleep state of a patient that may be implemented in an implantable medical device.
  • the techniques provided by the invention may include analysis of a variety of physiological parameters not previously used in determining whether a patient is asleep. Where it is desired to detect sleep via an implantable medical device, the ability to determine whether a patient is sleeping based on these physiological parameters may increase the number of implantable medical device types in which the invention may be implemented, i.e., the invention may be implemented in a variety of types of implantable medical devices which include or may be easily modified to include sensors capable of generating a signal based on such physiological parameters.
  • Monitoring a plurality of physiological parameters may allow for a more accurate determination of whether a patient is asleep than is available via existing implantable medical devices.
  • Use of sleep metrics that indicate a probability of the patient being asleep for each of a plurality of physiological parameters may further increase the reliability with which an implantable medical device may determine whether a patient is asleep.
  • sleep metric values for each of a plurality of parameters may be combined to yield an overall sleep metric value that may be compared to a threshold to determine whether the patient is asleep. In other words, failure of any one physiological parameter to accurately indicate whether a patient is sleeping may be less likely to prevent the implantable medical device from accurately indicating whether the patient is sleeping when considered in combination with other physiological parameters.
  • FIG. 1 is a conceptual diagram illustrating an example system including an implantable medical device that determines whether a patient is asleep according to the invention.
  • FIG. 2 is a block diagram further illustrating the system of FIG. 1 .
  • FIG. 3 is a block diagram illustrating a memory within an implantable medical device of the system of FIG. 1 .
  • FIG. 4 is a flowchart illustrating an example technique for determining whether a patient is asleep.
  • FIG. 1 is a conceptual diagram illustrating an example system 10 that includes an implantable medical device (IMD) 14 that determines whether a patient 12 is asleep according to the invention.
  • IMD 14 takes the form of an implantable neurostimulator that delivers neurostimulation therapy in the form of electrical pulses to patient 12 .
  • the invention is not limited to implementation via an implantable neurostimulator, or even to implementation via an IMD.
  • an implantable pump or implantable cardiac pacemaker may determine whether a patient is asleep.
  • a programming device may determine when patient 12 is asleep based on information collected by a medical device.
  • any implantable or external device may determine whether a patient is asleep according to the invention.
  • IMD 14 delivers neurostimulation therapy to patient 12 via leads 16 A and 16 B (collectively “leads 16 ”).
  • Leads 16 may, as shown in FIG. 1 , be implanted proximate to the spinal cord 18 of patient 12 , and IMD 14 may deliver spinal cord stimulation (SCS) therapy to patient 12 in order to, for example, reduce pain experienced by patient 12 .
  • SCS spinal cord stimulation
  • the invention is not limited to the configuration of leads 16 shown in FIG. 1 or the delivery of SCS therapy.
  • one or more leads 16 may extend from MD 14 to the brain (not shown) of patient 12 , and IMD 14 may deliver deep brain stimulation (DBS) therapy to patient 12 to, for example, treat tremor or epilepsy.
  • DBS deep brain stimulation
  • one or more leads 16 may be implanted proximate to the pelvic nerves (not shown) or stomach (not shown), and IMD 14 may deliver neurostimulation therapy to treat incontinence or gastroparesis.
  • IMD 14 delivers therapy according to a set of therapy parameters that define the delivered therapy.
  • the parameters for each of the parameter sets may include voltage or current pulse amplitudes, pulse widths, pulse rates, and the like.
  • each of leads 16 includes electrodes (not shown in FIG. 1 ), and the parameters may include information identifying which electrodes have been selected for delivery of pulses, and the polarities of the selected electrodes.
  • System 10 also includes a clinician programmer 20 .
  • a clinician may use clinician programmer 20 to program neurostimulation therapy for patient 12 .
  • Clinician programmer 20 may, as shown in FIG. 1 , be a handheld computing device.
  • Clinician programmer 20 includes a display 22 , such as a LCD or LED display, to display information to a user.
  • Clinician programmer 20 may also include a keypad 24 , which may be used by a user to interact with clinician programmer 20 .
  • display 22 may be a touch screen display, and a user may interact with clinician programmer 20 via display 22 .
  • a user may also interact with clinician programmer 20 using peripheral pointing devices, such as a stylus, mouse, or the like.
  • Keypad 24 may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions.
  • System 10 also includes a patient programmer 26 , which also may, as shown in FIG. 1 , be a handheld computing device.
  • Patient 12 may use patient programmer 26 to control the delivery of neurostimulation therapy by IMD 14 .
  • Patient programmer 26 may also include a display 28 and a keypad 30 , to allow patient 12 to interact with patient programmer 26 .
  • display 26 may be a touch screen display, and patient 12 may interact with patient programmer 26 via display 28 .
  • Patient 12 may also interact with patient programmer 26 using peripheral pointing devices, such as a stylus or mouse.
  • IMD 14 , clinician programmer 20 and patient programmer 26 may, as shown in FIG. 1 , communicate via wireless communication.
  • Clinician programmer 20 and patient programmer 26 may, for example, communicate via wireless communication with IMD 14 using RF telemetry techniques known in the art.
  • Clinician programmer 20 and patient programmer 26 may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802.11 or Bluetooth specification sets, infrared communication according to the IRDA specification set, or other standard or proprietary telemetry protocols.
  • Clinician programmer 20 and patient programmer 26 need not communicate wirelessly, however.
  • programmers 20 and 26 may communicate via a wired connection, such as via a serial communication cable, or via exchange of removable media, such as magnetic or optical disks, or memory cards or sticks.
  • clinician programmer 20 may communicate with one or both of IMD 14 and patient programmer 26 via remote telemetry techniques known in the art, communicating via a local area network (LAN), wide area network (WAN), public switched telephone network (PSTN), or cellular telephone network, for example.
  • LAN local area network
  • WAN wide area network
  • PSTN public switched telephone network
  • cellular telephone network for example.
  • IMD 14 is capable of determining whether patient 12 is asleep. Specifically, as will be described in greater detail below, IMD 14 monitors a plurality of physiological parameters of patient 12 that may discernibly change when patient 12 is asleep, and determines whether patient 12 is asleep based on values of the physiological parameters.
  • the value for a physiological parameter may be a current, mean or median value for the parameter.
  • IMD 14 may additionally or alternatively determine whether patient 12 is asleep based on the variability of one or more of the physiological parameters.
  • IMD 14 includes, is coupled to, or is in wireless communication with one or more sensors, and monitors the physiological parameters via the sensors.
  • Exemplary physiological parameters that may be monitored by IMD 14 include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, and arterial blood flow.
  • galvanic skin response may additionally or alternatively be monitored.
  • Some of the parameters, such as activity level, heart rate, respiration rate, respiratory volume, blood pressure, arterial oxygen saturation and partial pressure, partial pressure of oxygen in the cerebrospinal fluid, muscular activity, core temperature, arterial blood flow, and galvanic skin response may be at low values when patient 12 is asleep. Further, the variability of at least some of these parameters, such as heart rate and respiration rate, may be at a low value when the patient is asleep.
  • Information regarding the posture of patient 12 will most likely indicate that patient 12 is lying down when patient 12 is asleep.
  • IMD 14 determines a value of one or more sleep metrics based on a value of one or more physiological parameters of patient 12 .
  • a sleep metric value may be a numeric value that indicates the probability that patient 12 is asleep.
  • the sleep metric value may be a probability value, e.g., a number within the range from 0 to 1.
  • the IMD 14 may apply a function or look-up table to the current, mean or median value, and/or the variability of the physiological parameter to determine a value of the sleep metric.
  • IMD 14 may compare the sleep metric value to a threshold value to determine whether the patient is asleep.
  • the IMD 14 may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of the patient, e.g., rapid eye movement (REM), S 1 , S 2 , S 3 , or S 4 . Because they provide the most “refreshing” type of sleep, the ability to determine whether the patient is in one of the S 3 and S 4 sleep states may be, in some embodiments, particularly useful.
  • REM rapid eye movement
  • IMD 14 may determine a sleep metric value for each of a plurality of physiological parameters. In other words, IMD 14 may apply a function or look-up table for each parameter to a value for that parameter in order to determine the sleep metric value for that parameter. IMD 14 may average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value for comparison to the threshold values. In some embodiments, IMD 14 may apply a weighting factor to one or more of the sleep metric values prior to combination.
  • One or more of functions, look-up tables, thresholds and weighting factors may be selected or adjusted by a user, such as a clinician via programmer 20 or patient 12 via programmer 26 , in order to select or adjust the sensitivity and specificity of IMD 14 in determining whether patient 12 is asleep.
  • Monitoring a plurality of physiological parameters may allow IMD 14 to determine whether patient 12 is asleep with more accuracy than existing implantable medical devices.
  • Use of sleep metric values that indicate a probability of the patient being asleep for each of a plurality of physiological parameters may further increase the accuracy with which IMD 14 may determine whether patient 12 is asleep.
  • sleep metric values for each of a plurality of parameters may be combined to yield an overall sleep metric value that may be compared to a threshold to determine whether patient 12 is asleep. In other words, failure of any one physiological parameter to accurately indicate whether a patient is sleeping may be less likely to prevent IMD 14 from accurately indicating whether patient 12 is sleeping when considered in combination with other physiological parameters.
  • IMD 14 may control delivery of therapy to patient 12 based on the determination as to whether patient 12 is asleep. For example, IMD 14 may suspend delivery of neurostimulation or reduce the intensity of delivered neurostimulation when patient 14 is determined to be asleep. In other embodiments, IMD 14 may suspend or reduce intensity of drug delivery, or may reduce the aggressiveness of rate response for cardiac pacing when patient 12 is determined to be asleep. In still other embodiments, IMD 14 may initiate delivery of a therapy, such as a therapy to treat or prevent sleep apnea, when patient 12 is determined to be asleep.
  • a therapy such as a therapy to treat or prevent sleep apnea
  • IMD 14 stores information indicating when patient 12 is asleep, which may be retrieved for analysis by a clinician via programmer 20 , for example.
  • the clinician may use the sleep information to diagnose conditions of patient 12 , such as sleep apnea or psychological disorders.
  • Information relating to the sleep patterns of patient 12 may in other situations indicate the effectiveness of a delivered therapy and/or the need for increased therapy.
  • Some ailments of patient 12 such as chronic pain, tremor, gastrointestinal disorders, incontinence, congestive heart failure, and sleep apnea may disturb or hinder the sleep or patient 12 , or, in some cases, inadequate or disturbed sleep may increase the symptoms of these ailments.
  • IMD 14 may collect information relating to the sleep patterns of patient 12 , which may be retrieved by a clinician via programmer 20 and used to evaluate the effectiveness of a therapy delivered to patient 12 for such an ailment, or to indicate the need for an additional therapy to improve the sleep pattern of patient 12 . In some cases, IMD 14 may evaluate such collected sleep information and automatically adjust a therapy for such a condition based on the evaluation. Further information regarding evaluation of a therapy based on sleep information collected by an IMD may be found in a commonly-assigned and copending U.S. patent application by Ken Heruth and Keith Miesel, entitled “COLLECTING SLEEP QUALITY INFORMATION VIA A MEDICAL DEVICE,” which is filed on Apr.
  • FIG. 2 is a block diagram further illustrating system 10 .
  • FIG. 2 illustrates an example configuration of IMD 14 and leads 16 A and 16 B.
  • FIG. 2 also illustrates sensors 40 A and 40 B (collectively “sensors 40 ”) that generate signals as a function of one or more physiological parameters of patient 12 .
  • IMD 14 monitors the signals to determine whether patient 12 is asleep.
  • IMD 14 may deliver neurostimulation therapy via electrodes 42 A-D of lead 16 A and electrodes 42 E-H of lead 16 B (collectively “electrodes 42 ”). Electrodes 42 may be ring electrodes. The configuration, type and number of electrodes 42 illustrated in FIG. 2 are merely exemplary. For example, leads 16 A and 16 B may each include eight electrodes 42 , and the electrodes 42 need not be arranged linearly on each of leads 16 A and 16 B.
  • Electrodes 42 are electrically coupled to a therapy delivery module 44 via leads 16 A and 16 B.
  • Therapy delivery module 44 may, for example, include a pulse generator coupled to a power source such as a battery. Therapy delivery module 44 may deliver electrical pulses to patient 12 via at least some of electrodes 42 under the control of a processor 46 , which controls therapy delivery module 44 to deliver neurostimulation therapy according to a set of therapy parameters, which may be one of a plurality of therapy parameter sets stored in memory 48 .
  • a therapy delivery module 44 of an IMD may include a pump, circuitry to control the pump, and a reservoir to store a therapeutic agent for delivery via the pump.
  • Processor 46 may include a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or the like.
  • Memory 48 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, and the like.
  • RAM random access memory
  • ROM read-only memory
  • NVRAM non-volatile RAM
  • EEPROM electrically-erasable programmable ROM
  • flash memory and the like.
  • memory 48 stores program instructions that, when executed by processor 46 , cause IMD 14 and processor 46 to perform the functions attributed to them herein.
  • Each of sensors 40 generates a signal as a function of one or more physiological parameters of patient 12 .
  • system 10 may include any number of sensors.
  • sensors 40 may be included as part of IMD 14 , or coupled to IMD 14 via leads 16 .
  • Sensors 40 may be coupled to IMD 14 via therapy leads 16 A and 16 B, or via other leads 16 , such as lead 16 C depicted in FIG. 2 .
  • a sensor located outside of IMD 14 may be in wireless communication with processor 46 .
  • exemplary physiological parameters of patient 12 that may be monitored by IMD 14 to determine values of one or more sleep metrics include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, and arterial blood flow.
  • galvanic skin response may additionally or alternatively be monitored.
  • the detected values of these physiological parameters of patient 12 may discernibly change when patient 12 falls asleep or wakes up. In particular, these physiological parameters may be at low values when patient 12 is asleep. Further, the variability of at least some of these parameters, such as heart rate and respiration rate, may be at a low value when the patient is asleep.
  • Sensors 40 may be of any type known in the art capable of generating a signal as a function of one or more of these parameters.
  • sensors 40 may include electrodes located on leads or integrated as part of the housing of IMD 14 that generate an electrogram signal as a function of electrical activity of the heart of patient 12 , and processor 46 may monitor the heart rate of patient 12 based on the electrogram signal.
  • a sensor may include an acoustic sensor within IMD 14 , a pressure or flow sensor within the bloodstream or cerebrospinal fluid of patient 12 , or a temperature sensor located within the bloodstream of patient 12 . The signals generated by such sensors may vary as a function of contraction of the heart of patient 12 , and can be used by IMD 14 to monitor the heart rate of patient 12 .
  • Sensors 40 may include one or more accelerometers, gyros, mercury switches, or bonded piezoelectric crystals that generate a signal as a function of patient activity, e.g., body motion, footfalls or other impact events, and the like. Sensors 40 may also include a plurality of accelerometers, gyros, or magnetometers oriented orthogonally that generate signals that indicate the posture of patient 12 . In addition to being oriented orthogonally with respect to each other, each of sensors 40 used to detect the posture of patient 12 may be generally aligned with an axis of the body of patient 12 .
  • the magnitude and polarity of DC components of the signals generate by the accelerometers indicate the orientation of the patient relative to the Earth's gravity, e.g., the posture of patient 12 .
  • Further information regarding use of orthogonally aligned accelerometers to determine patient posture may be found in a commonly-assigned U.S. Pat. No. 5,593,431, which issued to Todd J. Sheldon.
  • sensors 40 may include an electrode pair, including one electrode integrated with the housing of IMD 14 and one of electrodes 42 , that generates a signal as a function of the thoracic impedance of patient 12 , which varies as a function of respiration by patient 12 .
  • sensors 40 may include a strain gauge, bonded piezoelectric element, or pressure sensor within the blood or cerebrospinal fluid that generates a signal that varies based on patient respiration.
  • An electrogram generated by electrodes as discussed above may also be modulated by patient respiration, and may be used as an indirect representation of respiration rate.
  • Sensors 40 may include electrodes that generate an electromyogram (EMG) signal as a function of muscle electrical activity, or may include any of a variety of known temperature sensors to generate a signal as a function of a core temperature of patient 12 . Such electrodes and temperature sensors may be incorporated within the housing of IMD 14 , or coupled to IMD 14 via leads. Sensors 40 may also include a pressure sensor within, or in contact with, a blood vessel. The pressure sensor may generate a signal as a function of the a blood pressure of patient 12 , and may, for example, comprise a Chronicle Hemodynamic MonitorTM commercially available from Medtronic, Inc. of Minneapolis, Minn.
  • EMG electromyogram
  • Sensors 40 may also include optical pulse oximetry sensors or Clark dissolved oxygen sensors located within, as part of a housing of, or outside of IMD 14 , which generate signals as a function of blood oxygen saturation and blood oxygen partial pressure respectively.
  • system 10 may include a catheter with a distal portion located within the cerebrospinal fluid of patient 12 , and the distal end may include a Clark sensor to generate a signal as a function of the partial pressure of oxygen within the cerebrospinal fluid.
  • an IMD comprises an implantable pump, for example, may include a catheter with a distal portion located in the cerebrospinal fluid.
  • sensors 40 may include one or more intraluminal, extraluminal, or external flow sensors positioned to generate a signal as a function of arterial blood flow.
  • a flow sensor may be, for example, an electromagnetic, thermal convection, ultrasonic-Doppler, or laser-Doppler flow sensor.
  • sensors 40 may include one or more electrodes positioned on the skin of patient 12 to generate a signal as a function of galvanic skin response.
  • Processor 46 monitors the physiological parameters based on the signals generated by the one or more sensors 40 , and determines whether patient 12 is asleep based on current values for the physiological parameters.
  • processor 46 may determine mean or median value for the parameter based on values of the signal over time, and determines whether patient 12 is asleep based on the mean or median value.
  • processor 46 may additionally or alternatively determine a variability of one or more of the parameters based on the values of the parameter over time, and may determine whether patient 12 is asleep based on the one or more variability values.
  • IMD 14 may include circuitry (not shown) that conditions the signals generate by sensors 40 such that they may be analyzed by processor 46 .
  • IMD 14 may include one or more analog to digital converters to convert analog signals generate by sensors 40 into digital signals usable by processor 46 , as well as suitable filter and amplifier circuitry.
  • processor 46 determines a value of a sleep metric that indicates a probability of the patient being asleep based on a physiological parameter.
  • processor 46 may apply a function or look-up table to the current value, mean or median value, and/or variability of the physiological parameter to determine the sleep metric value.
  • the values of one or more physiological parameters serve as indices to the lookup table to yield a corresponding output value, which serves as the sleep metric value.
  • Processor 46 may compare the sleep metric value to a threshold value to determine whether patient 12 is asleep.
  • processor 46 may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of patient 12 , e.g., rapid eye movement (REM), S 1 , S 2 , S 3 , or S 4 .
  • REM rapid eye movement
  • processor 46 determines a sleep metric value for each of a plurality of monitored physiological parameters.
  • processor 46 may apply a function or look-up table for each parameter to the current value for that parameter in order to determine the sleep metric value for that individual parameter.
  • Processor 46 may then average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value, and may determine whether patient 12 is asleep based on the overall sleep metric value.
  • processor 46 may apply a weighting factor to one or more of the sleep metric values prior to combination.
  • memory 48 may include parameter information 60 recorded by processor 46 , e.g., parameter values, or mean or median parameter values.
  • Memory 48 may also store sleep metric functions 62 or look-up tables (not shown) that processor 46 may retrieve for application to physiological parameter values or variability values, and threshold values 64 that processor 46 may use to determine whether patient 12 is asleep and, in some embodiments, the sleep state of patient 12 .
  • Memory 48 may also store weighting factors 66 used by processor 46 when combining sleep metric values to determine an overall sleep metric value.
  • Processor 46 may store sleep information 68 within memory 48 , such as recorded sleep metric values and information indicating when patient 12 was asleep.
  • IMD 14 also includes a telemetry circuit 50 that allows processor 46 to communicate with clinician programmer 20 and patient programmer 26 .
  • a clinician may direct processor 46 to retrieve sleep information 68 from memory 48 and transmit the information via telemetry circuit 50 to programmer 20 for analysis.
  • the clinician may select or adjust the one or more of functions 62 , look-up tables, thresholds 64 and weighting factors 66 in order to select or adjust the sensitivity and specificity of processor 46 determining whether the patient is asleep.
  • FIG. 4 is a flowchart illustrating an example technique for determining whether a patient is asleep that may be employed by IMD 14 .
  • IMD 14 monitors a plurality of physiological parameters of patient 12 ( 70 ). More particularly, processor 46 receives signals from one or more sensors 40 , and monitors the physiological parameters based on the signals.
  • Processor 46 applies a respective function 62 to current values, mean or median values, and/or variability values for each of physiological parameters to determine a sleep metric value for each of the parameters ( 72 ). Processor 46 then combines the various sleep metric values to determine a current overall sleep metric value ( 74 ). For example processor 46 may apply weighting factors 66 to one or more of the parameter specific sleep metric values, and then average the parameter specific sleep metric values in light of the weighting factors 66 .
  • Processor 46 compares the current overall sleep metric value to a threshold value 64 ( 76 ), and determines whether patient 12 is asleep or awake, e.g., whether the sleep state of patient 12 has changed, based on the comparison ( 78 ). For example, processor 46 may determine that patient 12 is asleep if the current overall sleep metric value exceeds the threshold value 64 . If the sleep state of patient 12 has changed, processor 46 may initiate, suspend or adjust a therapy delivered to patient 12 by IMD 14 , or processor 46 may store an indication of the time and the change within memory 48 ( 80 ).
  • the invention may, as described above, be used to determine what level of sleep a patient is currently experiencing, e.g., which of sleep states REM, S 1 , S 2 , S 3 , and S 4 the patient is currently in.
  • a medical device may record transitions between these states and between sleep and wakefulness, or may control therapy based on transitions between these states and between sleep and wakefulness. Further, in some embodiments, a medical device may, without making a sleep determination, simply record one or more determined sleep metric values for later analysis, or may control delivery of therapy based on the sleep metric values.
  • a programming device may determine when patient 12 is asleep according to the invention instead of, or in addition to an implantable or external medical device.
  • a medical device may record values for one or more of the physiological parameters discussed herein, and may provide the physiological parameter values to the programming device in real time or when interrogated by the programming device.
  • the programming device may apply the techniques described herein with reference to IMD 14 to determine when patient 12 is asleep, and may control delivery of therapy based on the determination, or present information relating to the patient's sleep patterns to a user to enable diagnosis or therapy evaluation.
  • the invention may also be embodied as a computer-readable medium, such as memory 48 , that includes instructions to cause a processor, such as processor 46 , to perform any of the methods described herein.

Abstract

A system includes one or more sensors and a processor. Each of the sensors generates a signal as a function of at least one physiological parameter of a patient that may discernibly change when the patient is asleep. The processor monitors the physiological parameters, and determines whether the patient is asleep based on the parameters. In some embodiments, the processor determines plurality of sleep metric values, each of which indicates a probability of the patient being asleep, based on each of a plurality of physiological parameters. The processor may average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value that is compared to a threshold value in order to determine whether the patient is asleep.

Description

  • This application claims the benefit of U.S. Provisional Application No. 60/553,771, filed Mar. 16, 2004, which is incorporated herein by reference in its entirety.
  • TECHNICAL FIELD
  • The invention relates to medical devices, and to techniques for determining whether a patient is asleep.
  • BACKGROUND
  • The ability to determine whether a patient is asleep is useful in a variety of medical contexts. In some situations, the ability to determine whether a patient is asleep is used to diagnose conditions of the patient. For example, the amount of time that patients sleep, the extent of arousals during sleep, and the times of day that patients sleep have been used to diagnose sleep apnea. Such sleep information could also be used to diagnose psychological disorders, such as depression and mania.
  • In other situations, a determination as to whether a patient is asleep is used to control delivery of therapy to the patient. For example, neurostimulation or drug therapies can be suspended when the patient is asleep, or the intensity/dosage of the therapies can be reduced when a patient is asleep. As another example, the rate response settings of a cardiac pacemaker may be adjusted to less aggressive settings when the patient is asleep so that the patient's heart will not be paced at an inappropriately high rate during sleep. In these examples, therapy may be suspended or adjusted when the patient is asleep to avoid patient discomfort, or to conserve a battery and/or contents of a fluid reservoir of an implantable medical device when the therapy may be unneeded or ineffective. However, in other cases, a therapy intended to be delivered when the patient is asleep, such as therapy intended to prevent or treat sleep apnea, is delivered based on a determination that the patient is asleep.
  • Existing techniques for determining whether a patient is asleep include monitoring the electroencephalogram (EEG) of the patient to identify brain wave activity indicative of sleep. However, EEG monitoring typically requires that an array of electrodes be placed on a patient's scalp and coupled to an external monitoring device, and is most often performed in a clinic setting. Generally, an implantable medical device may only be used to monitor a patient's EEG in the rare cases when it is coupled to electrodes implanted within the brain of the patient. Consequently, EEG monitoring is generally unsuitable as a technique for determining whether a patient is asleep in order to control therapy, or for long-term monitoring of the patient's sleep/wake cycle.
  • Existing techniques employed by implantable medical devices to determine whether a patient is asleep include monitoring the patient's respiration rate, respiration rate variability, and activity level. Each of these physiological parameters may be an inaccurate indicator of whether a patient is asleep. For example, from the perspective of these physiological parameters, it may appear that a patient is sleeping when, instead, the patient is merely lying down in a relaxed state. As another example, respiration rate and respiration rate variability, for example, may fail to accurately indicate that the patient is asleep when the patient suffers from a breathing disorder, such as Cheyne-Stokes syndrome.
  • SUMMARY
  • In general, the invention is directed to techniques for determining whether a patient is asleep. In some embodiments, the invention is directed to techniques that involve determination of values of one or more sleep metrics that indicate a probability of a patient being asleep based on the current value of one or more physiological parameters of the patient. Use of a plurality of sleep metrics, in particular, may allow for a more accurate determination of whether a patient is asleep.
  • A system according to the invention includes one or more sensors and a processor. Each of the sensors generates a signal as a function of at least one physiological parameter of a patient that may discernibly change when the patient is asleep. Exemplary physiological parameters include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, arterial blood flow, and galvanic skin response.
  • The processor monitors the physiological parameters based on the signals generated by the sensors, and determines whether the patient is asleep based on values for the physiological parameters. The value for a physiological parameter may be a current, mean or median value for the parameter. In some embodiments, the processor may additionally or alternatively determine whether the patient is asleep based on the variability of one or more of the physiological parameters.
  • In some embodiments, the processor determines a value of a sleep metric that indicates a probability of the patient being asleep based on a physiological parameter. In particular, the processor may apply a function or look-up table to the current value and/or variability of the physiological parameter to determine the sleep metric value. The processor may compare the sleep metric value to a threshold value to determine whether the patient is asleep. In some embodiments, the processor may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of the patient, e.g., rapid eye movement (REM), or one of the nonrapid eye movement (NREM) states (S1, S2, S3, S4). Because they provide the most “refreshing” type of sleep, the ability to determine whether the patient is in one of the S3 and S4 sleep states may be, in some embodiments, particularly useful.
  • Further, in some embodiments the processor may determine a sleep metric value for each of a plurality of physiological parameters. In other words, the processor may apply a function or look-up table for each parameter to the current value for that parameter in order to determine the sleep metric value for that parameter. The processor may average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value for comparison to the threshold values. In some embodiments, a weighting factor may be applied to one or more of the sleep metric values. One or more of functions, look-up tables, thresholds and weighting factors may be selected or adjusted by a user in order to select or adjust the sensitivity and specificity of the system in determining whether the patient is asleep.
  • In some embodiments, the processor is included as part of a medical device, such as an implantable medical device. The sensors may also be included within the medical device, coupled to the medical device by one or more leads, or in wireless communication with the medical device. The medical device may control delivery of therapy to the patient based on the determination as to whether the patient is asleep, or may store information indicating when the patient is asleep for later retrieval and analysis by user. In some embodiments, the medical device may instead use the one or more sleep metric values to control delivery of therapy, or may store one or more sleep metric values. In some embodiments, information relating to the patient's sleep patterns may be used to diagnose sleep or psychological disorder, or may be used to evaluate the effectiveness of a therapy delivered to the patient.
  • In one embodiment, the invention is directed to a method in which a plurality of physiological parameters of a patient are monitored and a value of a sleep metric that indicates a probability of the patient being asleep is determined based on the physiological parameters.
  • In another embodiment, the invention is directed to a medical system that comprises at least one sensor and a processor. The sensor generates a signal as a function of at least one physiological parameter of a patient. The processor receives the signal from the sensor, monitors a plurality of physiological parameters of the patient, and determines a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • In another embodiment, the invention is directed to a medical system that comprises means for monitoring a plurality of physiological parameters of a patient and means for determining a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • In another embodiment, the invention is directed to a method in which a physiological parameter of a patient is monitored via an implantable medical device, and whether the patient is asleep is determined based on the physiological parameter. The physiological parameter comprises one of heart rate, blood pressure, blood oxygen saturation, muscular activity and core temperature.
  • In another embodiment, the invention is directed to a medical system that comprises a sensor and an implantable medical device. The sensor generates a signal as a function of a physiological parameter of a patient. The physiological parameter comprises one of heart rate, blood pressure, blood oxygen saturation, muscular activity, core temperature, arterial blood flow, and galvanic skin response. The implantable medical device includes a processor that monitors the physiological parameter based on the signal and determines whether the patient is asleep based on the physiological parameter.
  • In another embodiment, the invention is directed to a computer-readable medium comprising program instructions. The instructions cause a programmable processor to monitor a plurality of physiological parameters of a patient, and determine a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
  • The invention may be capable of providing one or more advantages. For example, the invention provides techniques for determining a sleep state of a patient that may be implemented in an implantable medical device. Further, the techniques provided by the invention may include analysis of a variety of physiological parameters not previously used in determining whether a patient is asleep. Where it is desired to detect sleep via an implantable medical device, the ability to determine whether a patient is sleeping based on these physiological parameters may increase the number of implantable medical device types in which the invention may be implemented, i.e., the invention may be implemented in a variety of types of implantable medical devices which include or may be easily modified to include sensors capable of generating a signal based on such physiological parameters.
  • Monitoring a plurality of physiological parameters according to some embodiments, rather than a single parameter, may allow for a more accurate determination of whether a patient is asleep than is available via existing implantable medical devices. Use of sleep metrics that indicate a probability of the patient being asleep for each of a plurality of physiological parameters may further increase the reliability with which an implantable medical device may determine whether a patient is asleep. In particular, rather than a binary sleep or awake determination for each of a plurality of parameters, sleep metric values for each of a plurality of parameters may be combined to yield an overall sleep metric value that may be compared to a threshold to determine whether the patient is asleep. In other words, failure of any one physiological parameter to accurately indicate whether a patient is sleeping may be less likely to prevent the implantable medical device from accurately indicating whether the patient is sleeping when considered in combination with other physiological parameters.
  • The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
  • BRIEF DESCRIPTION OF DRAWINGS
  • FIG. 1 is a conceptual diagram illustrating an example system including an implantable medical device that determines whether a patient is asleep according to the invention.
  • FIG. 2 is a block diagram further illustrating the system of FIG. 1.
  • FIG. 3 is a block diagram illustrating a memory within an implantable medical device of the system of FIG. 1.
  • FIG. 4 is a flowchart illustrating an example technique for determining whether a patient is asleep.
  • DETAILED DESCRIPTION
  • FIG. 1 is a conceptual diagram illustrating an example system 10 that includes an implantable medical device (IMD) 14 that determines whether a patient 12 is asleep according to the invention. In the illustrated example system, IMD 14 takes the form of an implantable neurostimulator that delivers neurostimulation therapy in the form of electrical pulses to patient 12. However, the invention is not limited to implementation via an implantable neurostimulator, or even to implementation via an IMD.
  • For example, in some embodiments of the invention, an implantable pump or implantable cardiac pacemaker may determine whether a patient is asleep. In other embodiments, a programming device may determine when patient 12 is asleep based on information collected by a medical device. In other words, any implantable or external device may determine whether a patient is asleep according to the invention.
  • In the illustrated example, IMD 14 delivers neurostimulation therapy to patient 12 via leads 16A and 16B (collectively “leads 16”). Leads 16 may, as shown in FIG. 1, be implanted proximate to the spinal cord 18 of patient 12, and IMD 14 may deliver spinal cord stimulation (SCS) therapy to patient 12 in order to, for example, reduce pain experienced by patient 12. However, the invention is not limited to the configuration of leads 16 shown in FIG. 1 or the delivery of SCS therapy. For example, one or more leads 16 may extend from MD 14 to the brain (not shown) of patient 12, and IMD 14 may deliver deep brain stimulation (DBS) therapy to patient 12 to, for example, treat tremor or epilepsy. As further examples, one or more leads 16 may be implanted proximate to the pelvic nerves (not shown) or stomach (not shown), and IMD 14 may deliver neurostimulation therapy to treat incontinence or gastroparesis.
  • IMD 14 delivers therapy according to a set of therapy parameters that define the delivered therapy. In embodiments where IMD 14 delivers neurostimulation therapy in the form of electrical pulses, the parameters for each of the parameter sets may include voltage or current pulse amplitudes, pulse widths, pulse rates, and the like. Further, each of leads 16 includes electrodes (not shown in FIG. 1), and the parameters may include information identifying which electrodes have been selected for delivery of pulses, and the polarities of the selected electrodes.
  • System 10 also includes a clinician programmer 20. A clinician (not shown) may use clinician programmer 20 to program neurostimulation therapy for patient 12. Clinician programmer 20 may, as shown in FIG. 1, be a handheld computing device. Clinician programmer 20 includes a display 22, such as a LCD or LED display, to display information to a user. Clinician programmer 20 may also include a keypad 24, which may be used by a user to interact with clinician programmer 20. In some embodiments, display 22 may be a touch screen display, and a user may interact with clinician programmer 20 via display 22. A user may also interact with clinician programmer 20 using peripheral pointing devices, such as a stylus, mouse, or the like. Keypad 24 may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions.
  • System 10 also includes a patient programmer 26, which also may, as shown in FIG. 1, be a handheld computing device. Patient 12 may use patient programmer 26 to control the delivery of neurostimulation therapy by IMD 14. Patient programmer 26 may also include a display 28 and a keypad 30, to allow patient 12 to interact with patient programmer 26. In some embodiments, display 26 may be a touch screen display, and patient 12 may interact with patient programmer 26 via display 28. Patient 12 may also interact with patient programmer 26 using peripheral pointing devices, such as a stylus or mouse.
  • IMD 14, clinician programmer 20 and patient programmer 26 may, as shown in FIG. 1, communicate via wireless communication. Clinician programmer 20 and patient programmer 26 may, for example, communicate via wireless communication with IMD 14 using RF telemetry techniques known in the art. Clinician programmer 20 and patient programmer 26 may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802.11 or Bluetooth specification sets, infrared communication according to the IRDA specification set, or other standard or proprietary telemetry protocols.
  • Clinician programmer 20 and patient programmer 26 need not communicate wirelessly, however. For example, programmers 20 and 26 may communicate via a wired connection, such as via a serial communication cable, or via exchange of removable media, such as magnetic or optical disks, or memory cards or sticks. Further, clinician programmer 20 may communicate with one or both of IMD 14 and patient programmer 26 via remote telemetry techniques known in the art, communicating via a local area network (LAN), wide area network (WAN), public switched telephone network (PSTN), or cellular telephone network, for example.
  • As mentioned above, IMD 14 is capable of determining whether patient 12 is asleep. Specifically, as will be described in greater detail below, IMD 14 monitors a plurality of physiological parameters of patient 12 that may discernibly change when patient 12 is asleep, and determines whether patient 12 is asleep based on values of the physiological parameters. The value for a physiological parameter may be a current, mean or median value for the parameter. In some embodiments, IMD 14 may additionally or alternatively determine whether patient 12 is asleep based on the variability of one or more of the physiological parameters. IMD 14 includes, is coupled to, or is in wireless communication with one or more sensors, and monitors the physiological parameters via the sensors.
  • Exemplary physiological parameters that may be monitored by IMD 14 include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, and arterial blood flow. In some external medical device embodiments of the invention, galvanic skin response may additionally or alternatively be monitored. Some of the parameters, such as activity level, heart rate, respiration rate, respiratory volume, blood pressure, arterial oxygen saturation and partial pressure, partial pressure of oxygen in the cerebrospinal fluid, muscular activity, core temperature, arterial blood flow, and galvanic skin response may be at low values when patient 12 is asleep. Further, the variability of at least some of these parameters, such as heart rate and respiration rate, may be at a low value when the patient is asleep. Information regarding the posture of patient 12 will most likely indicate that patient 12 is lying down when patient 12 is asleep.
  • In some embodiments, IMD 14 determines a value of one or more sleep metrics based on a value of one or more physiological parameters of patient 12. A sleep metric value may be a numeric value that indicates the probability that patient 12 is asleep. In some embodiments, the sleep metric value may be a probability value, e.g., a number within the range from 0 to 1.
  • In particular, the IMD 14 may apply a function or look-up table to the current, mean or median value, and/or the variability of the physiological parameter to determine a value of the sleep metric. IMD 14 may compare the sleep metric value to a threshold value to determine whether the patient is asleep. In some embodiments, the IMD 14 may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of the patient, e.g., rapid eye movement (REM), S1, S2, S3, or S4. Because they provide the most “refreshing” type of sleep, the ability to determine whether the patient is in one of the S3 and S4 sleep states may be, in some embodiments, particularly useful.
  • Further, in some embodiments IMD 14 may determine a sleep metric value for each of a plurality of physiological parameters. In other words, IMD 14 may apply a function or look-up table for each parameter to a value for that parameter in order to determine the sleep metric value for that parameter. IMD 14 may average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value for comparison to the threshold values. In some embodiments, IMD 14 may apply a weighting factor to one or more of the sleep metric values prior to combination. One or more of functions, look-up tables, thresholds and weighting factors may be selected or adjusted by a user, such as a clinician via programmer 20 or patient 12 via programmer 26, in order to select or adjust the sensitivity and specificity of IMD 14 in determining whether patient 12 is asleep.
  • Monitoring a plurality of physiological parameters according to some embodiments, rather than a single parameter, may allow IMD 14 to determine whether patient 12 is asleep with more accuracy than existing implantable medical devices. Use of sleep metric values that indicate a probability of the patient being asleep for each of a plurality of physiological parameters may further increase the accuracy with which IMD 14 may determine whether patient 12 is asleep. In particular, rather than a binary sleep or awake determination for each of a plurality of parameters, sleep metric values for each of a plurality of parameters may be combined to yield an overall sleep metric value that may be compared to a threshold to determine whether patient 12 is asleep. In other words, failure of any one physiological parameter to accurately indicate whether a patient is sleeping may be less likely to prevent IMD 14 from accurately indicating whether patient 12 is sleeping when considered in combination with other physiological parameters.
  • IMD 14 may control delivery of therapy to patient 12 based on the determination as to whether patient 12 is asleep. For example, IMD 14 may suspend delivery of neurostimulation or reduce the intensity of delivered neurostimulation when patient 14 is determined to be asleep. In other embodiments, IMD 14 may suspend or reduce intensity of drug delivery, or may reduce the aggressiveness of rate response for cardiac pacing when patient 12 is determined to be asleep. In still other embodiments, IMD 14 may initiate delivery of a therapy, such as a therapy to treat or prevent sleep apnea, when patient 12 is determined to be asleep.
  • In some embodiments, IMD 14 stores information indicating when patient 12 is asleep, which may be retrieved for analysis by a clinician via programmer 20, for example. The clinician may use the sleep information to diagnose conditions of patient 12, such as sleep apnea or psychological disorders. Information relating to the sleep patterns of patient 12 may in other situations indicate the effectiveness of a delivered therapy and/or the need for increased therapy. Some ailments of patient 12, such as chronic pain, tremor, gastrointestinal disorders, incontinence, congestive heart failure, and sleep apnea may disturb or hinder the sleep or patient 12, or, in some cases, inadequate or disturbed sleep may increase the symptoms of these ailments.
  • IMD 14 may collect information relating to the sleep patterns of patient 12, which may be retrieved by a clinician via programmer 20 and used to evaluate the effectiveness of a therapy delivered to patient 12 for such an ailment, or to indicate the need for an additional therapy to improve the sleep pattern of patient 12. In some cases, IMD 14 may evaluate such collected sleep information and automatically adjust a therapy for such a condition based on the evaluation. Further information regarding evaluation of a therapy based on sleep information collected by an IMD may be found in a commonly-assigned and copending U.S. patent application by Ken Heruth and Keith Miesel, entitled “COLLECTING SLEEP QUALITY INFORMATION VIA A MEDICAL DEVICE,” which is filed on Apr. 15, 2004 and assigned attorney docket number 1023-250US01. Further information regarding automatic control of a therapy based on sleep information collected by an IMD may be found in a commonly-assigned and copending U.S. patent application by Ken Heruth and Keith Miesel, entitled “CONTROLLING THERAPY BASED ON SLEEP QUALITY,” which is filed on Apr. 15, 2004 and assigned attorney docket number 1023-363US01. The entire content of both of these applications is incorporated herein by reference.
  • FIG. 2 is a block diagram further illustrating system 10. In particular, FIG. 2 illustrates an example configuration of IMD 14 and leads 16A and 16B. FIG. 2 also illustrates sensors 40A and 40B (collectively “sensors 40”) that generate signals as a function of one or more physiological parameters of patient 12. IMD 14 monitors the signals to determine whether patient 12 is asleep.
  • IMD 14 may deliver neurostimulation therapy via electrodes 42A-D of lead 16A and electrodes 42E-H of lead 16B (collectively “electrodes 42”). Electrodes 42 may be ring electrodes. The configuration, type and number of electrodes 42 illustrated in FIG. 2 are merely exemplary. For example, leads 16A and 16B may each include eight electrodes 42, and the electrodes 42 need not be arranged linearly on each of leads 16A and 16B.
  • Electrodes 42 are electrically coupled to a therapy delivery module 44 via leads 16A and 16B. Therapy delivery module 44 may, for example, include a pulse generator coupled to a power source such as a battery. Therapy delivery module 44 may deliver electrical pulses to patient 12 via at least some of electrodes 42 under the control of a processor 46, which controls therapy delivery module 44 to deliver neurostimulation therapy according to a set of therapy parameters, which may be one of a plurality of therapy parameter sets stored in memory 48. However, the invention is not limited to implantable neurostimulator embodiments or even to IMDs that deliver electrical stimulation. For example, in some embodiments a therapy delivery module 44 of an IMD may include a pump, circuitry to control the pump, and a reservoir to store a therapeutic agent for delivery via the pump.
  • Processor 46 may include a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or the like. Memory 48 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, and the like. In some embodiments, memory 48 stores program instructions that, when executed by processor 46, cause IMD 14 and processor 46 to perform the functions attributed to them herein.
  • Each of sensors 40 generates a signal as a function of one or more physiological parameters of patient 12. Although shown as including two sensors 40, system 10 may include any number of sensors. As illustrated in FIG. 2, sensors 40 may be included as part of IMD 14, or coupled to IMD 14 via leads 16. Sensors 40 may be coupled to IMD 14 via therapy leads 16A and 16B, or via other leads 16, such as lead 16C depicted in FIG. 2. In some embodiments, a sensor located outside of IMD 14 may be in wireless communication with processor 46.
  • As discussed above, exemplary physiological parameters of patient 12 that may be monitored by IMD 14 to determine values of one or more sleep metrics include activity level, posture, heart rate, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, and arterial blood flow. Further, as discussed above, in some external medical device embodiments of the invention galvanic skin response may additionally or alternatively be monitored. The detected values of these physiological parameters of patient 12 may discernibly change when patient 12 falls asleep or wakes up. In particular, these physiological parameters may be at low values when patient 12 is asleep. Further, the variability of at least some of these parameters, such as heart rate and respiration rate, may be at a low value when the patient is asleep. Sensors 40 may be of any type known in the art capable of generating a signal as a function of one or more of these parameters.
  • For example, sensors 40 may include electrodes located on leads or integrated as part of the housing of IMD 14 that generate an electrogram signal as a function of electrical activity of the heart of patient 12, and processor 46 may monitor the heart rate of patient 12 based on the electrogram signal. In other embodiments, a sensor may include an acoustic sensor within IMD 14, a pressure or flow sensor within the bloodstream or cerebrospinal fluid of patient 12, or a temperature sensor located within the bloodstream of patient 12. The signals generated by such sensors may vary as a function of contraction of the heart of patient 12, and can be used by IMD 14 to monitor the heart rate of patient 12.
  • Sensors 40 may include one or more accelerometers, gyros, mercury switches, or bonded piezoelectric crystals that generate a signal as a function of patient activity, e.g., body motion, footfalls or other impact events, and the like. Sensors 40 may also include a plurality of accelerometers, gyros, or magnetometers oriented orthogonally that generate signals that indicate the posture of patient 12. In addition to being oriented orthogonally with respect to each other, each of sensors 40 used to detect the posture of patient 12 may be generally aligned with an axis of the body of patient 12. When accelerometers, for example, are aligned in this manner, the magnitude and polarity of DC components of the signals generate by the accelerometers indicate the orientation of the patient relative to the Earth's gravity, e.g., the posture of patient 12. Further information regarding use of orthogonally aligned accelerometers to determine patient posture may be found in a commonly-assigned U.S. Pat. No. 5,593,431, which issued to Todd J. Sheldon.
  • In some embodiments, sensors 40 may include an electrode pair, including one electrode integrated with the housing of IMD 14 and one of electrodes 42, that generates a signal as a function of the thoracic impedance of patient 12, which varies as a function of respiration by patient 12. In other embodiments, sensors 40 may include a strain gauge, bonded piezoelectric element, or pressure sensor within the blood or cerebrospinal fluid that generates a signal that varies based on patient respiration. An electrogram generated by electrodes as discussed above may also be modulated by patient respiration, and may be used as an indirect representation of respiration rate.
  • Sensors 40 may include electrodes that generate an electromyogram (EMG) signal as a function of muscle electrical activity, or may include any of a variety of known temperature sensors to generate a signal as a function of a core temperature of patient 12. Such electrodes and temperature sensors may be incorporated within the housing of IMD 14, or coupled to IMD 14 via leads. Sensors 40 may also include a pressure sensor within, or in contact with, a blood vessel. The pressure sensor may generate a signal as a function of the a blood pressure of patient 12, and may, for example, comprise a Chronicle Hemodynamic Monitor™ commercially available from Medtronic, Inc. of Minneapolis, Minn.
  • Sensors 40 may also include optical pulse oximetry sensors or Clark dissolved oxygen sensors located within, as part of a housing of, or outside of IMD 14, which generate signals as a function of blood oxygen saturation and blood oxygen partial pressure respectively. In some embodiments, system 10 may include a catheter with a distal portion located within the cerebrospinal fluid of patient 12, and the distal end may include a Clark sensor to generate a signal as a function of the partial pressure of oxygen within the cerebrospinal fluid. Embodiments in which an IMD comprises an implantable pump, for example, may include a catheter with a distal portion located in the cerebrospinal fluid.
  • In some embodiments, sensors 40 may include one or more intraluminal, extraluminal, or external flow sensors positioned to generate a signal as a function of arterial blood flow. A flow sensor may be, for example, an electromagnetic, thermal convection, ultrasonic-Doppler, or laser-Doppler flow sensor. Further, in some external medical device embodiments of the invention, sensors 40 may include one or more electrodes positioned on the skin of patient 12 to generate a signal as a function of galvanic skin response.
  • Processor 46 monitors the physiological parameters based on the signals generated by the one or more sensors 40, and determines whether patient 12 is asleep based on current values for the physiological parameters. In some embodiments, processor 46 may determine mean or median value for the parameter based on values of the signal over time, and determines whether patient 12 is asleep based on the mean or median value. In other embodiments, processor 46 may additionally or alternatively determine a variability of one or more of the parameters based on the values of the parameter over time, and may determine whether patient 12 is asleep based on the one or more variability values. IMD 14 may include circuitry (not shown) that conditions the signals generate by sensors 40 such that they may be analyzed by processor 46. For example, IMD 14 may include one or more analog to digital converters to convert analog signals generate by sensors 40 into digital signals usable by processor 46, as well as suitable filter and amplifier circuitry.
  • In some embodiments, processor 46 determines a value of a sleep metric that indicates a probability of the patient being asleep based on a physiological parameter. In particular, processor 46 may apply a function or look-up table to the current value, mean or median value, and/or variability of the physiological parameter to determine the sleep metric value. For example, the values of one or more physiological parameters serve as indices to the lookup table to yield a corresponding output value, which serves as the sleep metric value. Processor 46 may compare the sleep metric value to a threshold value to determine whether patient 12 is asleep. In some embodiments, processor 46 may compare the sleep metric value to each of a plurality of thresholds to determine the current sleep state of patient 12, e.g., rapid eye movement (REM), S1, S2, S3, or S4.
  • Further, in some embodiments processor 46 determines a sleep metric value for each of a plurality of monitored physiological parameters. In other words, processor 46 may apply a function or look-up table for each parameter to the current value for that parameter in order to determine the sleep metric value for that individual parameter. Processor 46 may then average or otherwise combine the plurality of sleep metric values to provide an overall sleep metric value, and may determine whether patient 12 is asleep based on the overall sleep metric value. In some embodiments, processor 46 may apply a weighting factor to one or more of the sleep metric values prior to combination.
  • As shown in FIG. 3, memory 48 may include parameter information 60 recorded by processor 46, e.g., parameter values, or mean or median parameter values. Memory 48 may also store sleep metric functions 62 or look-up tables (not shown) that processor 46 may retrieve for application to physiological parameter values or variability values, and threshold values 64 that processor 46 may use to determine whether patient 12 is asleep and, in some embodiments, the sleep state of patient 12. Memory 48 may also store weighting factors 66 used by processor 46 when combining sleep metric values to determine an overall sleep metric value. Processor 46 may store sleep information 68 within memory 48, such as recorded sleep metric values and information indicating when patient 12 was asleep.
  • As shown in FIG. 2, IMD 14 also includes a telemetry circuit 50 that allows processor 46 to communicate with clinician programmer 20 and patient programmer 26. For example, using clinician programmer 20, a clinician may direct processor 46 to retrieve sleep information 68 from memory 48 and transmit the information via telemetry circuit 50 to programmer 20 for analysis. Further, the clinician may select or adjust the one or more of functions 62, look-up tables, thresholds 64 and weighting factors 66 in order to select or adjust the sensitivity and specificity of processor 46 determining whether the patient is asleep.
  • FIG. 4 is a flowchart illustrating an example technique for determining whether a patient is asleep that may be employed by IMD 14. According to the example technique, IMD 14 monitors a plurality of physiological parameters of patient 12 (70). More particularly, processor 46 receives signals from one or more sensors 40, and monitors the physiological parameters based on the signals.
  • Processor 46 applies a respective function 62 to current values, mean or median values, and/or variability values for each of physiological parameters to determine a sleep metric value for each of the parameters (72). Processor 46 then combines the various sleep metric values to determine a current overall sleep metric value (74). For example processor 46 may apply weighting factors 66 to one or more of the parameter specific sleep metric values, and then average the parameter specific sleep metric values in light of the weighting factors 66.
  • Processor 46 compares the current overall sleep metric value to a threshold value 64 (76), and determines whether patient 12 is asleep or awake, e.g., whether the sleep state of patient 12 has changed, based on the comparison (78). For example, processor 46 may determine that patient 12 is asleep if the current overall sleep metric value exceeds the threshold value 64. If the sleep state of patient 12 has changed, processor 46 may initiate, suspend or adjust a therapy delivered to patient 12 by IMD 14, or processor 46 may store an indication of the time and the change within memory 48 (80).
  • Various embodiments of the invention have been described. However, one skilled in the art will appreciated that various modifications may be made to the described embodiments without departing from the scope of the invention. For example, although described herein in the context of an implantable neurostimulator, the invention may be embodied in any implantable or external medical device.
  • As another example, although described in the context of determining whether a patient is asleep, e.g., whether the patient's current sleep state is asleep or awake, the invention may, as described above, be used to determine what level of sleep a patient is currently experiencing, e.g., which of sleep states REM, S1, S2, S3, and S4 the patient is currently in. A medical device may record transitions between these states and between sleep and wakefulness, or may control therapy based on transitions between these states and between sleep and wakefulness. Further, in some embodiments, a medical device may, without making a sleep determination, simply record one or more determined sleep metric values for later analysis, or may control delivery of therapy based on the sleep metric values.
  • Further, the invention may be embodied in a programming device, such as programmers 20, 26 described above. In particular, in some embodiments, a programming device may determine when patient 12 is asleep according to the invention instead of, or in addition to an implantable or external medical device. For example, a medical device may record values for one or more of the physiological parameters discussed herein, and may provide the physiological parameter values to the programming device in real time or when interrogated by the programming device. The programming device may apply the techniques described herein with reference to IMD 14 to determine when patient 12 is asleep, and may control delivery of therapy based on the determination, or present information relating to the patient's sleep patterns to a user to enable diagnosis or therapy evaluation.
  • The invention may also be embodied as a computer-readable medium, such as memory 48, that includes instructions to cause a processor, such as processor 46, to perform any of the methods described herein. These and other embodiments are within the scope of the following claims.

Claims (68)

1. A method comprising:
monitoring a plurality of physiological parameters of a patient; and
determining a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
2. The method of claim 1, wherein the physiological parameters comprise at least one of activity level, posture, heart rate, respiration rate, respiratory volume, and core temperature.
3. The method of claim 1, wherein the physiological parameters comprise at least one of blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, core temperature, arterial blood flow, and galvanic skin response.
4. The method of claim 1, further comprising determining a variability of at least one of the physiological parameters, wherein determining a value of the sleep metric comprises determining the value of the sleep metric based on the variability.
5. The method of claim 1, further comprising determining at least one of a mean value and a median value for at least one of the physiological parameters, wherein determining a value of a sleep metric comprises determining the sleep metric based on the at least one of the mean value and the median value.
6. The method of claim 1, wherein determining a value of a sleep metric comprises determining a value for each of a plurality of sleep metrics, each of the values determined based on a respective one of the physiological parameters.
7. The method of claim 6, wherein determining a value of a sleep metric comprises determining a value of an overall sleep metric based on the plurality of sleep metric values.
8. The method of claim 7, wherein determining a value of an overall sleep metric comprises averaging the values of the plurality of sleep metrics.
9. The method of claim 7, wherein determining a value of an overall sleep metric comprises applying a weighting factor to a value of at least one of the plurality of sleep metrics.
10. The method of claim 1, further comprising:
comparing the value of the sleep metric to a threshold value; and
determining whether the patient is asleep based on the comparison.
11. The method of claim 10, further comprising:
comparing the value of the sleep metric to a plurality of thresholds; and
determining a sleep state of the patient based on the comparison.
12. The method of claim 11, wherein determining a sleep state of the patient comprises determining whether the patient is in one of a rapid eye movement (REM) sleep state and a nonrapid eye movement (NREM) sleep state.
13. The method of claim 10, wherein the threshold value is selected by a user.
14. The method of claim 10, further comprising controlling delivery of a therapy to the patient based on the determination of whether the patient is asleep.
15. The method of claim 10, further comprising storing information indicating when the patient is asleep for retrieval by a user.
16. The method of claim 15, further comprising evaluating the effectiveness of a therapy delivered to the patient based on the information indicating whether the patient is asleep.
17. The method of claim 16, wherein the therapy comprises at least one of a neurostimulation and a drug therapy.
18. The method of claim 16, wherein the therapy is a pain therapy.
19. A medical system comprising:
a plurality of sensors, each of the sensors generating a signal as a function of at least one physiological parameter of a patient; and
a processor that monitors a plurality of physiological parameters of the patient based on the signals output by the sensors, and determines a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
20. The system of claim 19, wherein the physiological parameters comprise at least one of activity level, posture, heart rate, respiration rate, respiratory volume, and core temperature.
21. The system of claim 19, wherein physiological parameters comprise at least one of blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity, arterial blood flow, and galvanic skin response.
22. The system of claim 19, wherein the processor determines a variability of at least one of the physiological parameters, and determines the sleep metric based on the variability.
23. The system of claim 19, wherein the processor determines at least one of a mean value and a median value of at least one of the physiological parameters, and determines the sleep metric based on the at least one of the mean value and the median value.
24. The system of claim 19, wherein the processor determines a value of each of a plurality of sleep metrics, each of the plurality of values determined based on a respective one of the physiological parameters.
25. The system of claim 24, wherein the processor determines a value of an overall sleep metric based the values of the plurality of sleep metrics.
26. The system of claim 25, wherein the processor determines the value of the overall sleep metric by averaging the values of the plurality of sleep metrics.
27. The system of claim 26, wherein the processor applies a weighting factor to at least one of values of the plurality of sleep metrics.
28. The system of claim 19, further comprising a memory to store a threshold value, wherein the processor compares the value of the sleep metric to a threshold value and determines whether the patient is asleep based on the comparison.
29. The system of claim 28, wherein the memory stores a plurality of threshold values, and the processor compares the value of the sleep metric to each of the threshold values and determines a sleep state of the patient based on the comparison.
30. The system of claim 29, wherein the processor determines whether the patient is in one of a rapid eye movement (REM) sleep state and a nonrapid eye movement (NREM) sleep state.
31. The system of claim 28, further comprising a user interface, wherein a user selects the threshold via the user interface.
32. The system of claim 28, wherein the processor controls delivery of a therapy to the patient based on the determination of whether the patient is asleep.
33. The system of claim 28, wherein the processor stores information indicating when the patient is asleep within the memory for retrieval by a user.
34. The system of claim 19, further comprising an implantable medical device that includes the processor.
35. The system of claim 34, wherein the implantable medical device includes the sensor.
36. The system of claim 34, wherein the implantable medical device is coupled to the sensor via a lead.
37. The system of claim 34, wherein the implantable medical device is wirelessly coupled to the sensor.
38. The system of claim 34, wherein the implantable medical device comprises at least one of an implantable neurostimulator and an implantable pump.
39. A system comprising:
means for monitoring a plurality of physiological parameters of a patient; and
means for determining a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
40. The system of claim 39, further comprising means for generating at least one signal as a function of the physiological parameters, wherein the means for monitoring comprises means for monitoring the physiological parameters based on the signal.
41. The system of claim 39, wherein the means for determining a sleep metric comprises means for determining a value for each of a plurality of sleep metrics, each of the plurality of values determined based on a respective one of the physiological parameters.
42. The system of claim 41, wherein the means for determining a value of a sleep metric comprises means for determining a value of an overall sleep metric based the values of the plurality of sleep metrics.
43. The system of claim 41, further comprising means for comparing the value of the sleep metric to a threshold value and determining whether the patient is asleep based on the comparison.
44. The system of claim 43, further comprising:
means for delivering a therapy to the patient; and
means for controlling delivery of a therapy to the patient by the therapy delivery means based on the determination of whether the patient is asleep.
45. The system of claim 43, further comprising means for storing information indicating when the patient is asleep for retrieval by a user.
46. A method comprising:
monitoring a physiological parameter of a patient via an implantable medical device, wherein the physiological parameter comprises one of blood pressure, blood oxygen saturation, muscular activity, core temperature, arterial blood flow, and galvanic skin response; and
determining whether a patient is asleep based on the physiological parameter.
47. The method of claim 46, wherein monitoring a physiological parameter comprises monitoring a plurality of physiological parameters, and wherein determining whether a patient is asleep comprises determining whether the patient is asleep based on the plurality of physiological parameters.
48. The method of claim 47, wherein determining whether a patient is asleep comprises:
determining a value of a sleep metric that indicates a probability of the patient being asleep based on the plurality of physiological parameters;
comparing the value of the sleep metric to a threshold value; and
determining whether the patient is asleep based on the comparison.
49. The method of claim 48, wherein determining a sleep metric comprises:
determining a value of a sleep metric for each of the plurality of monitored physiological parameters; and
determining a value of an overall sleep metric based on the values of the plurality of sleep metrics, and
wherein determining whether the patient is asleep comprises determining whether the patient is asleep based on comparison of the value of the overall sleep metric to the threshold.
50. The method of claim 46, further comprising controlling delivery of a therapy to the patient based on the determination of whether the patient is asleep.
51. The method of claim 46, further comprising storing information indicating when the patient is asleep for retrieval by a user.
52. The method of claim 51, further comprising evaluating the effectiveness of a therapy delivered to the patient based on the information indicating whether the patient is asleep.
53. A medical system comprising:
a sensor to generate a signal as a function of a physiological parameter of a patient, wherein the physiological parameter comprises one of blood pressure, blood oxygen saturation, muscular activity, core temperature, arterial blood flow, and galvanic skin response; and
an implantable medical device that includes a processor to monitor the physiological parameter based on the signal and determine whether a patient is asleep based on the physiological parameter.
54. The system of claim 53,
further comprising a plurality of sensors that generate a signal as a function of a physiological parameter of a patient,
wherein the processor monitors a plurality of physiological parameters based on the signals and determines whether the patient is asleep based on the plurality of physiological parameters.
55. The system of claim 54,
wherein the implantable medical device further comprises a memory to store a threshold value, and
wherein the processor determines a value of a sleep metric that indicates a sleep state of the patient based on the plurality of physiological parameters, compares the value of the sleep metric to a threshold value, and determines whether the patient is asleep based on the comparison.
56. The system of claim 55, wherein the processor determines a value of a sleep metric for each of the plurality of monitored physiological parameters, determines a value of an overall sleep metric based on the values of the plurality of sleep metrics, and determines whether the patient is asleep based on comparison of the value of the overall sleep metric to the threshold.
57. The system of claim 53, wherein the processor controls delivery of a therapy to the patient based on the determination of whether the patient is asleep.
58. The system of claim 53,
wherein the implantable medical device further comprises a memory, and
wherein the processor stores information indicating when the patient is asleep within the memory for retrieval by a user.
59. The system of claim 53, wherein the implantable medical device includes the sensor.
60. The system of claim 53, wherein the implantable medical device is coupled to the sensor via a lead
61. The system of claim 53, wherein the implantable medical device is wirelessly coupled to the sensor.
62. The system of claim 53, wherein the implantable medical device comprises at least one of an implantable neurostimulator and an implantable pump.
63. A computer-readable medium comprising instructions that cause a programmable processor to:
monitor a plurality of physiological parameters of a patient; and
determine a value of a sleep metric that indicates a probability of the patient being asleep based on the physiological parameters.
64. The medium of claim 63, further comprising instructions that cause the processor to determine a variability of at least one of the physiological parameters, wherein the instructions that cause the processor to determine a value of the sleep metric comprise instructions that cause the processor to determine the value of the sleep metric based on the variability.
65. The medium of claim 63, further comprising instructions that cause the processor to:
determine a value for each of a plurality of sleep metrics, each of the values determined based on a respective one of the physiological parameters; and
determine a value of an overall sleep metric based on the plurality of sleep metric values.
66. The medium of claim 63, further comprising instructions that cause the processor to:
compare the value of the sleep metric to a threshold value; and
determine whether the patient is asleep based on the comparison.
67. The method of claim 66, further comprising instructions that cause the processor to:
compare the value of the sleep metric to a plurality of thresholds; and
determine a sleep state of the patient based on the comparison.
68. The medium of claim 67, wherein the instructions that cause the processor to determine a sleep state of the patient comprise instructions that cause the processor to determine whether the patient is in one of a rapid eye movement (REM) sleep state and a nonrapid eye movement (NREM) sleep state.
US10/825,964 2004-03-16 2004-04-15 Detecting sleep Abandoned US20050209512A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US10/825,964 US20050209512A1 (en) 2004-03-16 2004-04-15 Detecting sleep
US11/081,786 US7775993B2 (en) 2004-03-16 2005-03-16 Detecting sleep
EP05725806A EP1732436B1 (en) 2004-03-16 2005-03-16 Detecting sleep
DE602005020758T DE602005020758D1 (en) 2004-03-16 2005-03-16 PROOF OF SLEEP
AT05725806T ATE464836T1 (en) 2004-03-16 2005-03-16 PROOF OF SLEEP
PCT/US2005/008881 WO2005089641A1 (en) 2004-03-16 2005-03-16 Detecting sleep
US11/691,405 US8055348B2 (en) 2004-03-16 2007-03-26 Detecting sleep to evaluate therapy
US12/828,981 US20100274106A1 (en) 2004-03-16 2010-07-01 Detecting sleep
US13/249,862 US8332038B2 (en) 2004-03-16 2011-09-30 Detecting sleep to evaluate therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55377104P 2004-03-16 2004-03-16
US10/825,964 US20050209512A1 (en) 2004-03-16 2004-04-15 Detecting sleep

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/081,786 Continuation-In-Part US7775993B2 (en) 2004-03-16 2005-03-16 Detecting sleep

Publications (1)

Publication Number Publication Date
US20050209512A1 true US20050209512A1 (en) 2005-09-22

Family

ID=34963539

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/825,964 Abandoned US20050209512A1 (en) 2004-03-16 2004-04-15 Detecting sleep
US11/081,786 Expired - Fee Related US7775993B2 (en) 2004-03-16 2005-03-16 Detecting sleep
US12/828,981 Abandoned US20100274106A1 (en) 2004-03-16 2010-07-01 Detecting sleep

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/081,786 Expired - Fee Related US7775993B2 (en) 2004-03-16 2005-03-16 Detecting sleep
US12/828,981 Abandoned US20100274106A1 (en) 2004-03-16 2010-07-01 Detecting sleep

Country Status (5)

Country Link
US (3) US20050209512A1 (en)
EP (1) EP1732436B1 (en)
AT (1) ATE464836T1 (en)
DE (1) DE602005020758D1 (en)
WO (1) WO2005089641A1 (en)

Cited By (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215947A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Controlling therapy based on sleep quality
US20050222522A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Detecting sleep
US20050222643A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Collecting activity information to evaluate therapy
US20050234514A1 (en) * 2004-03-16 2005-10-20 Heruth Kenneth T Collecting posture information to evaluate therapy
US20050245988A1 (en) * 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20060009704A1 (en) * 2004-07-07 2006-01-12 Sanyo Electric Co., Ltd. Sleep state estimating device and program product
US20070015976A1 (en) * 2005-06-01 2007-01-18 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US20070123758A1 (en) * 2004-03-16 2007-05-31 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20070129622A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Wearable ambulatory data recorder
US20070250134A1 (en) * 2006-03-24 2007-10-25 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US20070270782A1 (en) * 2006-04-06 2007-11-22 Miesel Keith A Systems and methods of identifying catheter malfunctions using pressure sensing
US20070276439A1 (en) * 2004-03-16 2007-11-29 Medtronic, Inc. Collecting sleep quality information via a medical device
US20080009837A1 (en) * 2003-10-02 2008-01-10 Medtronic, Inc. Pressure sensing in implantable medical devices
US20080071324A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US20080071326A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Detecting sleep to evaluate therapy
US20080071150A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20080195166A1 (en) * 2007-02-09 2008-08-14 Felice Sun Devices and methods for monitoring physiological information relating to sleep with an implantable device
US20080243074A1 (en) * 2007-03-30 2008-10-02 Miesel Keith A Catheter malfunction determinations using physiologic pressure
WO2009002237A1 (en) * 2007-06-27 2008-12-31 St. Jude Medical Ab A method and device for detecting rem sleep
WO2009002238A1 (en) * 2007-06-27 2008-12-31 St. Jude Medical Ab A method and device for collecting rem sleep data
US20090082639A1 (en) * 2007-09-25 2009-03-26 Pittman Stephen D Automated Sleep Phenotyping
US20090082829A1 (en) * 2007-09-26 2009-03-26 Medtronic, Inc. Patient directed therapy control
US20090099627A1 (en) * 2007-10-16 2009-04-16 Medtronic, Inc. Therapy control based on a patient movement state
US20090118599A1 (en) * 2004-03-16 2009-05-07 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20090192556A1 (en) * 2008-01-25 2009-07-30 Medtronic, Inc. Sleep stage detection
US20090264789A1 (en) * 2007-09-26 2009-10-22 Medtronic, Inc. Therapy program selection
WO2009134475A1 (en) 2008-04-29 2009-11-05 Medtronic, Inc. Therapy program modification based on a therapy field model
US20100069841A1 (en) * 2003-10-02 2010-03-18 Medtronic, Inc. Determining catheter status
US20100174155A1 (en) * 2004-03-16 2010-07-08 Medtronic, Inc. Collecting sleep quality information via a medical device
US7792583B2 (en) 2004-03-16 2010-09-07 Medtronic, Inc. Collecting posture information to evaluate therapy
US7805196B2 (en) 2004-03-16 2010-09-28 Medtronic, Inc. Collecting activity information to evaluate therapy
US7881798B2 (en) 2004-03-16 2011-02-01 Medtronic Inc. Controlling therapy based on sleep quality
US20110040547A1 (en) * 2008-04-29 2011-02-17 Gerber Martin T Therapy program modification based on therapy guidelines
US20110112590A1 (en) * 2009-11-11 2011-05-12 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
US20110144456A1 (en) * 2008-08-19 2011-06-16 Koninklijke Philips Electrnics N.V. Monitoring the blood pressure of a patient
WO2012027286A1 (en) 2010-08-26 2012-03-01 Medtronic, Inc. Therapy for rapid eye movement behavior disorder (rbd)
US8135473B2 (en) 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8150531B2 (en) 2008-07-11 2012-04-03 Medtronic, Inc. Associating therapy adjustments with patient posture states
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US8209028B2 (en) 2008-07-11 2012-06-26 Medtronic, Inc. Objectification of posture state-responsive therapy based on patient therapy adjustments
US8219206B2 (en) 2008-07-11 2012-07-10 Medtronic, Inc. Dwell time adjustments for posture state-responsive therapy
US8231555B2 (en) 2009-04-30 2012-07-31 Medtronic, Inc. Therapy system including multiple posture sensors
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
US8332041B2 (en) 2008-07-11 2012-12-11 Medtronic, Inc. Patient interaction with posture-responsive therapy
US20120330114A1 (en) * 2010-03-08 2012-12-27 Koninklijke Philips Electronics N.V. System and method for obtaining an objective measure of dyspnea
US20130002417A1 (en) * 2010-03-11 2013-01-03 Toyota Jidosha Kabushiki Kaisha Biological state determination device
US8388555B2 (en) 2010-01-08 2013-03-05 Medtronic, Inc. Posture state classification for a medical device
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
US8401666B2 (en) 2008-07-11 2013-03-19 Medtronic, Inc. Modification profiles for posture-responsive therapy
US8437861B2 (en) 2008-07-11 2013-05-07 Medtronic, Inc. Posture state redefinition based on posture data and therapy adjustments
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8583233B2 (en) * 2011-07-29 2013-11-12 Medtronic, Inc. Modification of AV conduction time sampling rate
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US20140046153A1 (en) * 2010-12-16 2014-02-13 Stephen Frederick Woodford Monitoring volaemic condition in a human or animal subject
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8812098B2 (en) 2011-04-28 2014-08-19 Medtronic, Inc. Seizure probability metrics
US8868173B2 (en) 2011-04-20 2014-10-21 Medtronic, Inc. Method and apparatus for assessing neural activation
US8892207B2 (en) 2011-04-20 2014-11-18 Medtronic, Inc. Electrical therapy for facilitating inter-area brain synchronization
US8914119B2 (en) 2011-04-20 2014-12-16 Medtronic, Inc. Electrical brain therapy parameter determination based on a bioelectrical resonance response
US20150112158A1 (en) * 2013-10-23 2015-04-23 Quanttus, Inc. Health Metrics
US9033920B2 (en) 2003-10-02 2015-05-19 Medtronic, Inc. Determining catheter status
US9044537B2 (en) 2007-03-30 2015-06-02 Medtronic, Inc. Devices and methods for detecting catheter complications
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
WO2015104369A1 (en) * 2014-01-10 2015-07-16 Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) Systems for providing oxygen to a patient
WO2015164143A1 (en) 2014-04-25 2015-10-29 Medtronic, Inc. Deep brain stimulation for sleep disorders
US9173609B2 (en) 2011-04-20 2015-11-03 Medtronic, Inc. Brain condition monitoring based on co-activation of neural networks
US20160022203A1 (en) * 2014-09-23 2016-01-28 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
US9333351B2 (en) 2013-12-16 2016-05-10 Pacesetter, Inc. Neurostimulation method and system to treat apnea
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9789252B2 (en) 2008-04-29 2017-10-17 Medtronic, Inc. Therapy program modification based on a therapy field model
US9867955B2 (en) 2003-08-14 2018-01-16 New York University System and method for diagnosis and treatment of a breathing pattern of a patient
CN107595245A (en) * 2017-08-15 2018-01-19 深圳创达云睿智能科技有限公司 A kind of dormancy management method, system and terminal device
US9878161B2 (en) 2011-04-29 2018-01-30 Medtronic, Inc. Entrainment of bioelectrical brain signals
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9956418B2 (en) 2010-01-08 2018-05-01 Medtronic, Inc. Graphical manipulation of posture zones for posture-responsive therapy
US10111615B2 (en) 2017-03-11 2018-10-30 Fitbit, Inc. Sleep scoring based on physiological information
US10311745B2 (en) 2016-06-02 2019-06-04 Fitbit, Inc. Systems and techniques for tracking sleep consistency and sleep goals
US20190175103A1 (en) * 2017-12-07 2019-06-13 Paramount Bed Co., Ltd. Evaluating apparatus and non-transitory computer readable medium storing program
US10368744B1 (en) * 2015-02-17 2019-08-06 Halo Wearables, Llc Baselining user profiles from portable device information
US10471264B2 (en) 2005-12-02 2019-11-12 Medtronic, Inc. Closed-loop therapy adjustment
US10729352B2 (en) 2015-08-17 2020-08-04 Neuropace, Inc. Neurological event detection tools for implantable medical devices
US10806398B2 (en) 2015-02-17 2020-10-20 Halo Wearables, Llc Power management for wearable devices
US11207021B2 (en) 2016-09-06 2021-12-28 Fitbit, Inc Methods and systems for labeling sleep states
US11219408B2 (en) * 2016-08-25 2022-01-11 Night Train Oy Method and system for determining time window for sleep of a person
WO2022038710A1 (en) * 2020-08-19 2022-02-24 日本電信電話株式会社 Watching method, watching program, and watching device
US11273283B2 (en) 2017-12-31 2022-03-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
CN114259210A (en) * 2021-12-27 2022-04-01 上海交通大学 Sleep staging method and control system based on dynamic skin temperature
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US11483619B1 (en) 2021-08-31 2022-10-25 Rovi Guides, Inc. Measuring sleep state of a user using wearables and deciding on the playback option for the content consumed
US11596795B2 (en) 2017-07-31 2023-03-07 Medtronic, Inc. Therapeutic electrical stimulation therapy for patient gait freeze
US20230095780A1 (en) * 2019-07-25 2023-03-30 Inspire Medical Systems, Inc. Sleep detection for sleep disordered breathing (sdb) care
US11642531B2 (en) 2020-10-09 2023-05-09 Medtronic, Inc. Sensing cardiac signals with leads implanted in epidural space
US11642077B2 (en) 2016-04-29 2023-05-09 Fitbit, Inc. Sleep monitoring system with optional alarm functionality
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
WO2023241469A1 (en) * 2022-06-13 2023-12-21 华为技术有限公司 Sleep monitoring method and device

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004030480A1 (en) 2002-10-01 2004-04-15 Nellcor Puritan Bennett Incorporated Headband with tension indicator
US7047056B2 (en) 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
US8412297B2 (en) 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities
US9743878B2 (en) 2005-04-29 2017-08-29 Medtronic, Inc. Event-based lead impedance monitoring
US7623919B2 (en) * 2005-04-29 2009-11-24 Medtronic, Inc. Distributed lead functionality testing
US7733224B2 (en) 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US7677503B2 (en) * 2005-12-30 2010-03-16 Thomas & Betts International, Inc. Rework bracket for electrical outlet boxes
US20110009773A1 (en) * 2006-02-04 2011-01-13 Evigia Systems, Inc. Implantable sensing modules and methods of using
US8417329B2 (en) 2007-05-09 2013-04-09 Metacure Ltd. Analysis and regulation of food intake
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8423130B2 (en) * 2008-05-09 2013-04-16 Metacure Limited Optimization of thresholds for eating detection
WO2009140636A2 (en) 2008-05-15 2009-11-19 Inspire Medical Systems, Inc. Method and apparatus for sensing respiratory pressure in an implantable stimulation system
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
WO2010039853A1 (en) 2008-10-01 2010-04-08 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US20100100004A1 (en) * 2008-10-16 2010-04-22 Koninklijke Nederlandse Akademie Van Wetenschappen Skin Temperature Measurement in Monitoring and Control of Sleep and Alertness
EP2389224B1 (en) 2008-11-19 2017-03-01 Inspire Medical Systems, Inc. Device treating sleep disordered breathing
EP2391264A4 (en) * 2009-02-02 2013-12-25 Neurostream Technologies General Partnership A method and device for the prevention of sudden unexpected death in epilepsy (sudep)
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US9486628B2 (en) 2009-03-31 2016-11-08 Inspire Medical Systems, Inc. Percutaneous access for systems and methods of treating sleep apnea
GB2471902A (en) * 2009-07-17 2011-01-19 Sharp Kk Sleep management system which correlates sleep and performance data
US8831732B2 (en) 2010-04-29 2014-09-09 Cyberonics, Inc. Method, apparatus and system for validating and quantifying cardiac beat data quality
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
AU2011288191B2 (en) 2010-08-13 2016-03-17 Fisher & Paykel Healthcare Limited Apparatus and method for providing gases to a user
EP2621333B1 (en) 2010-09-28 2015-07-29 Masimo Corporation Depth of consciousness monitor including oximeter
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US9498162B2 (en) 2011-04-25 2016-11-22 Cyberonics, Inc. Identifying seizures using heart data from two or more windows
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
US9069380B2 (en) 2011-06-10 2015-06-30 Aliphcom Media device, application, and content management using sensory input
WO2013023218A1 (en) 2011-08-11 2013-02-14 Inspire Medical Systems, Inc. System for selecting a stimulation protocol based on sensed respiratory effort
US9549677B2 (en) 2011-10-14 2017-01-24 Flint Hills Scientific, L.L.C. Seizure detection methods, apparatus, and systems using a wavelet transform maximum modulus algorithm
EP3225891B1 (en) 2012-01-26 2020-06-03 MED-EL Elektromedizinische Geräte GmbH Neural monitoring systems for treating pharyngeal disorders
JP5515156B2 (en) * 2012-03-30 2014-06-11 株式会社タニタ Sleep management system and sleep meter
US10448839B2 (en) 2012-04-23 2019-10-22 Livanova Usa, Inc. Methods, systems and apparatuses for detecting increased risk of sudden death
US9681836B2 (en) 2012-04-23 2017-06-20 Cyberonics, Inc. Methods, systems and apparatuses for detecting seizure and non-seizure states
US10220211B2 (en) 2013-01-22 2019-03-05 Livanova Usa, Inc. Methods and systems to diagnose depression
US20150348260A1 (en) * 2014-05-29 2015-12-03 Siemens Aktiengesellschaft System and Method for Mapping Patient Data from One Physiological State to Another Physiological State
US10154815B2 (en) 2014-10-07 2018-12-18 Masimo Corporation Modular physiological sensors
EP3881892A1 (en) 2015-03-19 2021-09-22 Inspire Medical Systems, Inc. Stimulation for treating sleep disordered breathing
US11298074B2 (en) 2015-12-08 2022-04-12 Fisher & Paykel Healthcare Limited Flow-based sleep stage determination
EP3445444A1 (en) 2016-04-19 2019-02-27 Inspire Medical Systems, Inc. Accelerometer-based sensing for sleep disordered breathing (sdb) care
EP3518736B1 (en) 2016-09-27 2021-08-18 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US10610688B2 (en) 2016-09-27 2020-04-07 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
EP3532155A1 (en) 2016-10-25 2019-09-04 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
WO2018132529A1 (en) 2017-01-11 2018-07-19 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10926091B2 (en) 2017-01-11 2021-02-23 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
US10898718B2 (en) 2017-07-18 2021-01-26 Boston Scientific Neuromoduiation Corporation Sensor-based pain management systems and methods
EP3498151A1 (en) * 2017-12-14 2019-06-19 Koninklijke Philips N.V. Method and apparatus for determining onset of sleep
CN108490851A (en) * 2018-02-24 2018-09-04 胡天予 Infantal sleeping pedals monitored system and its monitoring method
CN110634267A (en) * 2018-06-25 2019-12-31 中国石油天然气股份有限公司 Sleep warning device and work clothes
WO2021016536A1 (en) 2019-07-25 2021-01-28 Inspire Medical Systems, Inc. Systems and methods for operating an implantable medical device based upon sensed posture information
US11896387B2 (en) 2020-06-02 2024-02-13 Pacesetter, Inc. Methods, systems, and devices for detecting sleep and apnea events
US20220211322A1 (en) * 2021-01-06 2022-07-07 Medtronic, Inc. Detection of changes in patient health based on sleep activity

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612467A (en) * 1898-10-18 John a
US4297685A (en) * 1979-05-31 1981-10-27 Environmental Devices Corporation Apparatus and method for sleep detection
US4550736A (en) * 1983-10-14 1985-11-05 Canadian Patents & Development Limited Movement artifact detector for sleep analysis
US4771780A (en) * 1987-01-15 1988-09-20 Siemens-Pacesetter, Inc. Rate-responsive pacemaker having digital motion sensor
US4776345A (en) * 1987-09-04 1988-10-11 Cns, Inc. Interactive determination of sleep stages
US4846195A (en) * 1987-03-19 1989-07-11 Intermedics, Inc. Implantable position and motion sensor
US5040536A (en) * 1990-01-31 1991-08-20 Medtronic, Inc. Intravascular pressure posture detector
US5058584A (en) * 1990-08-30 1991-10-22 Medtronic, Inc. Method and apparatus for epidural burst stimulation for angina pectoris
US5125412A (en) * 1990-07-23 1992-06-30 Thornton William E Musculoskeletal activity monitor
US5154180A (en) * 1990-01-24 1992-10-13 France Telecom Method and device for determining a subject's sleep state by processing an electroencephalographic signal
US5233984A (en) * 1991-03-29 1993-08-10 Medtronic, Inc. Implantable multi-axis position and activity sensor
US5275159A (en) * 1991-03-22 1994-01-04 Madaus Schwarzer Medizintechnik Gmbh & Co. Kg Method and apparatus for diagnosis of sleep disorders
US5335657A (en) * 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5337758A (en) * 1991-01-11 1994-08-16 Orthopedic Systems, Inc. Spine motion analyzer and method
US5340409A (en) * 1992-04-23 1994-08-23 Canon Kabushiki Kaisha Photovoltaic element and method for forming the same
US5469861A (en) * 1992-04-17 1995-11-28 Mark F. Piscopo Posture monitor
US5514162A (en) * 1994-06-07 1996-05-07 Pacesetter, Inc. System and method for automatically determining the slope of a transfer function for a rate-responsive cardiac pacemaker
US5593431A (en) * 1995-03-30 1997-01-14 Medtronic, Inc. Medical service employing multiple DC accelerometers for patient activity and posture sensing and method
US5622428A (en) * 1994-12-30 1997-04-22 Ela Medical S.A. Method and apparatus for determination of a criterion of activity of a rate modulation parameter sensor in an active implantable medical device
US5645053A (en) * 1991-11-14 1997-07-08 University Technologies International, Inc. Auto CPAP system and method for preventing patient disturbance using airflow profile information
US5732696A (en) * 1992-03-17 1998-03-31 New York University Polysomnograph scoring
US5782884A (en) * 1996-11-05 1998-07-21 Sulzer Intermedics Inc. Rate responsive cardiac pacemaker with peak impedance detection for rate control
US5895371A (en) * 1996-08-27 1999-04-20 Sabratek Corporation Medical treatment apparatus and method
US5904708A (en) * 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
US5919149A (en) * 1996-03-19 1999-07-06 Allum; John H. Method and apparatus for angular position and velocity based determination of body sway for the diagnosis and rehabilitation of balance and gait disorders
US5941906A (en) * 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
US6044297A (en) * 1998-09-25 2000-03-28 Medtronic, Inc. Posture and device orientation and calibration for implantable medical devices
US6045513A (en) * 1998-05-13 2000-04-04 Medtronic, Inc. Implantable medical device for tracking patient functional status
US6059576A (en) * 1997-11-21 2000-05-09 Brann; Theodore L. Training and safety device, system and method to aid in proper movement during physical activity
US6095991A (en) * 1998-07-23 2000-08-01 Individual Monitoring Systems, Inc. Ambulatory body position monitor
US6120467A (en) * 1998-04-30 2000-09-19 Medtronic Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US6128534A (en) * 1998-06-16 2000-10-03 Pacesetter, Inc. Implantable cardiac stimulation device and method for varying pacing parameters to mimic circadian cycles
US6259948B1 (en) * 1998-11-13 2001-07-10 Pacesetter, Inc. Medical device
US6296606B1 (en) * 1993-12-17 2001-10-02 Charles Goldberg Patient thermal support device
US20010031930A1 (en) * 1999-12-19 2001-10-18 Roizen Michael F. Alarm upon detection of impending sleep state
US6308098B1 (en) * 1998-09-08 2001-10-23 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Process for detection of physical position of a human being
US20010037067A1 (en) * 2000-05-09 2001-11-01 Patrick Tchou System and method for monitoring progression of cardiac disease state using physiologic sensors
US6351672B1 (en) * 1999-07-22 2002-02-26 Pacesetter, Inc. System and method for modulating the pacing rate based on patient activity and position
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US20020077562A1 (en) * 2000-12-15 2002-06-20 James Kalgren System and method for correlation of patient health information and implant device data
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US20020091308A1 (en) * 2001-01-09 2002-07-11 Kipshidze Nicholas N. Method and apparatus for the synchronized therapeutic treatment of a life form
US6449508B1 (en) * 1999-10-21 2002-09-10 Medtronic, Inc. Accelerometer count calculation for activity signal for an implantable medical device
US6459934B1 (en) * 2000-07-21 2002-10-01 Cardiac Pacemakers, Inc. Estimate of efficiency using acceleration-heart rate ratio
US6466821B1 (en) * 1999-12-08 2002-10-15 Pacesetter, Inc. AC/DC multi-axis accelerometer for determining patient activity and body position
US6468234B1 (en) * 2000-07-14 2002-10-22 The Board Of Trustees Of The Leland Stanford Junior University SleepSmart
US20020161412A1 (en) * 2001-04-25 2002-10-31 Cardiac Pacemakers, Inc. Determination of long-term condition of cardiac patients
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US20030004423A1 (en) * 2000-03-02 2003-01-02 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US6514218B2 (en) * 2000-01-07 2003-02-04 Minolta Co., Ltd. Posture detecting device and breathing function measuring device
US6539249B1 (en) * 1998-05-11 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for assessing patient well-being
US6574507B1 (en) * 1998-07-06 2003-06-03 Ela Medical S.A. Active implantable medical device for treating sleep apnea syndrome by electrostimulation
US20030139692A1 (en) * 2000-02-04 2003-07-24 Eric Barrey Method for analysing irregularities in human locomotion
US20030149457A1 (en) * 2002-02-05 2003-08-07 Neuropace, Inc. Responsive electrical stimulation for movement disorders
US6605038B1 (en) * 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US20030153956A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Cardiac stimulation device including sleep apnea prevention and treatment
US20030153955A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Cardiac stimulation device including sleep apnea prevention and treatment
US6611783B2 (en) * 2000-01-07 2003-08-26 Nocwatch, Inc. Attitude indicator and activity monitoring device
US20030163059A1 (en) * 2001-12-07 2003-08-28 Yann Poezevera Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US20030171791A1 (en) * 2002-03-06 2003-09-11 Kenknight Bruce H. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US20030195588A1 (en) * 2002-04-16 2003-10-16 Neuropace, Inc. External ear canal interface for the treatment of neurological disorders
US20040002741A1 (en) * 2002-06-26 2004-01-01 Weinberg Lisa P. System and method for tracking progression of left ventricular dysfunction using implantable cardiac stimulation device
US20040002742A1 (en) * 2002-06-27 2004-01-01 Florio Joseph J. Using activity-based rest disturbance as a metric of sleep apnea
US20040015103A1 (en) * 2000-10-05 2004-01-22 Kamiar Aminian Body movement monitoring system and method
US6687538B1 (en) * 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
US20040049132A1 (en) * 2000-06-15 2004-03-11 The Procter & Gamble Company Device for body activity detection and processing
US6731984B2 (en) * 2001-06-07 2004-05-04 Medtronic, Inc. Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same
US20040102814A1 (en) * 2002-11-22 2004-05-27 Chris Sorensen Physician programmer system with telemetered sensor waveform
US20040111040A1 (en) * 2002-12-04 2004-06-10 Quan Ni Detection of disordered breathing
US20040111041A1 (en) * 2002-12-04 2004-06-10 Quan Ni Sleep detection using an adjustable threshold
US6752766B2 (en) * 2001-01-30 2004-06-22 Peter Kowallik Method and device for sleep monitoring
US20050021104A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050021103A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050042589A1 (en) * 2003-08-18 2005-02-24 Hatlestad John D. Sleep quality data collection and evaluation
US6878121B2 (en) * 2002-11-01 2005-04-12 David T. Krausman Sleep scoring apparatus and method
US6881192B1 (en) * 2002-06-12 2005-04-19 Pacesetter, Inc. Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
US20050085738A1 (en) * 2003-09-18 2005-04-21 Stahmann Jeffrey E. Sleep logbook
US6884596B2 (en) * 2000-04-28 2005-04-26 The Regents Of The University Of California Screening and therapeutic methods for promoting wakefulness and sleep
US6890306B2 (en) * 2001-12-14 2005-05-10 Ela Medical S.A. Active medical device for the diagnosis of the sleep apnea syndrome
US20050113710A1 (en) * 2003-09-18 2005-05-26 Stahmann Jeffrey E. Implantable device employing movement sensing for detecting sleep-related disorders
US20050119703A1 (en) * 1998-08-05 2005-06-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050177192A1 (en) * 2002-02-01 2005-08-11 Ali Rezai Neurostimulation for affecting sleep disorders
US20050215847A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Collecting sleep quality information via a medical device
US20050222626A1 (en) * 1998-08-05 2005-10-06 Dilorenzo Daniel J Cloosed-loop feedback-driven neuromodulation
US20050240242A1 (en) * 1998-08-05 2005-10-27 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US20050240086A1 (en) * 2004-03-12 2005-10-27 Metin Akay Intelligent wearable monitor systems and methods
US20060224191A1 (en) * 1998-08-05 2006-10-05 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US7162304B1 (en) * 2003-05-08 2007-01-09 Advanced Bionics Corporation System for measuring cardiac rhythm parameters for assessment of spinal cord stimulation
US7207947B2 (en) * 2003-01-10 2007-04-24 Pacesetter, Inc. System and method for detecting circadian states using an implantable medical device
US20070142862A1 (en) * 1998-08-05 2007-06-21 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278190A (en) 1989-11-30 1994-01-11 Clintec Nutrition Co. Method for improving the quality of sleep and treating sleep disorders
US5031618A (en) 1990-03-07 1991-07-16 Medtronic, Inc. Position-responsive neuro stimulator
US5476483A (en) 1994-06-10 1995-12-19 Pacesetter, Inc. System and method for modulating the base rate during sleep for a rate-responsive cardiac pacemaker
GB9522872D0 (en) 1995-11-08 1996-01-10 Oxford Medical Ltd Improvements relating to physiological monitoring
DE19653773C1 (en) 1996-12-21 1998-07-02 Ggt Ges Fuer Gerontotechnik Mb Method and arrangement for recording fall situations of people at risk of health
DE29719250U1 (en) 1997-10-30 1998-05-07 Hauptverband Der Gewerblichen Body stress measurement and analysis system
NL1008619C2 (en) 1998-03-17 1999-10-01 Robert Christiaan Van Lummel Method for measuring and indicating the degree to which a person is limited in activities of daily life.
DE19831109A1 (en) 1998-07-11 2000-01-13 Univ Schiller Jena Monitoring and evaluation of infants and new born breathing cycle
US6157857A (en) 1998-07-24 2000-12-05 Dimpfel; Wilfried Apparatus for determining sleep staging
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
DE10024103A1 (en) 2000-05-18 2001-11-29 Baumgart Schmitt Rudolf Arrangement for improving sleep quality by thermal stimulation has several thermoelectric units driven if sleep-related breathing problem automatically detected in real time
US6659968B1 (en) 2000-06-01 2003-12-09 Advanced Bionics Corporation Activity monitor for pain management efficacy measurement
US6641542B2 (en) 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
KR20080096855A (en) * 2001-06-13 2008-11-03 컴퓨메딕스 리미티드 Methods and apparatus for monitoring consciousness
US6662047B2 (en) 2001-09-05 2003-12-09 Pacesetter, Inc. Pacing mode to reduce effects of orthostatic hypotension and syncope
US6751503B1 (en) 2001-11-01 2004-06-15 Pacesetter, Inc. Methods and systems for treating patients with congestive heart failure (CHF)
US7123967B2 (en) 2002-05-13 2006-10-17 Pacesetter, Inc. Implantable neural stimulation device providing activity, rest, and long term closed-loop peripheral vascular disease therapy and method
SE0202948D0 (en) 2002-10-04 2002-10-04 Bergfalk & Knagenhjelm Ab Ways of detecting activity patterns that indicate mental illness, and corresponding arrangements
EP2008581B1 (en) * 2003-08-18 2011-08-17 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US6964641B2 (en) 2003-12-24 2005-11-15 Medtronic, Inc. Implantable medical device with sleep disordered breathing monitoring
US20050209512A1 (en) 2004-03-16 2005-09-22 Heruth Kenneth T Detecting sleep
US7330760B2 (en) 2004-03-16 2008-02-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US7366572B2 (en) 2004-03-16 2008-04-29 Medtronic, Inc. Controlling therapy based on sleep quality
US7395113B2 (en) 2004-03-16 2008-07-01 Medtronic, Inc. Collecting activity information to evaluate therapy
US7491181B2 (en) 2004-03-16 2009-02-17 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US7542803B2 (en) 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
WO2005102449A1 (en) 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612467A (en) * 1898-10-18 John a
US4297685A (en) * 1979-05-31 1981-10-27 Environmental Devices Corporation Apparatus and method for sleep detection
US4550736A (en) * 1983-10-14 1985-11-05 Canadian Patents & Development Limited Movement artifact detector for sleep analysis
US4771780A (en) * 1987-01-15 1988-09-20 Siemens-Pacesetter, Inc. Rate-responsive pacemaker having digital motion sensor
US4846195A (en) * 1987-03-19 1989-07-11 Intermedics, Inc. Implantable position and motion sensor
US4776345A (en) * 1987-09-04 1988-10-11 Cns, Inc. Interactive determination of sleep stages
US5154180A (en) * 1990-01-24 1992-10-13 France Telecom Method and device for determining a subject's sleep state by processing an electroencephalographic signal
US5040536A (en) * 1990-01-31 1991-08-20 Medtronic, Inc. Intravascular pressure posture detector
US5125412A (en) * 1990-07-23 1992-06-30 Thornton William E Musculoskeletal activity monitor
US5058584A (en) * 1990-08-30 1991-10-22 Medtronic, Inc. Method and apparatus for epidural burst stimulation for angina pectoris
US5337758A (en) * 1991-01-11 1994-08-16 Orthopedic Systems, Inc. Spine motion analyzer and method
US5275159A (en) * 1991-03-22 1994-01-04 Madaus Schwarzer Medizintechnik Gmbh & Co. Kg Method and apparatus for diagnosis of sleep disorders
US5233984A (en) * 1991-03-29 1993-08-10 Medtronic, Inc. Implantable multi-axis position and activity sensor
US5335657A (en) * 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5645053A (en) * 1991-11-14 1997-07-08 University Technologies International, Inc. Auto CPAP system and method for preventing patient disturbance using airflow profile information
US5732696A (en) * 1992-03-17 1998-03-31 New York University Polysomnograph scoring
US5469861A (en) * 1992-04-17 1995-11-28 Mark F. Piscopo Posture monitor
US5340409A (en) * 1992-04-23 1994-08-23 Canon Kabushiki Kaisha Photovoltaic element and method for forming the same
US6296606B1 (en) * 1993-12-17 2001-10-02 Charles Goldberg Patient thermal support device
US5514162A (en) * 1994-06-07 1996-05-07 Pacesetter, Inc. System and method for automatically determining the slope of a transfer function for a rate-responsive cardiac pacemaker
US5622428A (en) * 1994-12-30 1997-04-22 Ela Medical S.A. Method and apparatus for determination of a criterion of activity of a rate modulation parameter sensor in an active implantable medical device
US5593431A (en) * 1995-03-30 1997-01-14 Medtronic, Inc. Medical service employing multiple DC accelerometers for patient activity and posture sensing and method
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US5919149A (en) * 1996-03-19 1999-07-06 Allum; John H. Method and apparatus for angular position and velocity based determination of body sway for the diagnosis and rehabilitation of balance and gait disorders
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
US5895371A (en) * 1996-08-27 1999-04-20 Sabratek Corporation Medical treatment apparatus and method
US5782884A (en) * 1996-11-05 1998-07-21 Sulzer Intermedics Inc. Rate responsive cardiac pacemaker with peak impedance detection for rate control
US5941906A (en) * 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US6059576A (en) * 1997-11-21 2000-05-09 Brann; Theodore L. Training and safety device, system and method to aid in proper movement during physical activity
US5904708A (en) * 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
US6440090B1 (en) * 1998-04-30 2002-08-27 Medtronic, Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US6120467A (en) * 1998-04-30 2000-09-19 Medtronic Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US6539249B1 (en) * 1998-05-11 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for assessing patient well-being
US6102874A (en) * 1998-05-13 2000-08-15 Medtronic, Inc. Implantable medical device for tracking patient functional status
US6280409B1 (en) * 1998-05-13 2001-08-28 Medtronic, Inc. Medical for tracking patient functional status
US6045513A (en) * 1998-05-13 2000-04-04 Medtronic, Inc. Implantable medical device for tracking patient functional status
US6128534A (en) * 1998-06-16 2000-10-03 Pacesetter, Inc. Implantable cardiac stimulation device and method for varying pacing parameters to mimic circadian cycles
US6574507B1 (en) * 1998-07-06 2003-06-03 Ela Medical S.A. Active implantable medical device for treating sleep apnea syndrome by electrostimulation
US6095991A (en) * 1998-07-23 2000-08-01 Individual Monitoring Systems, Inc. Ambulatory body position monitor
US20060224191A1 (en) * 1998-08-05 2006-10-05 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US20070142862A1 (en) * 1998-08-05 2007-06-21 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US20050222626A1 (en) * 1998-08-05 2005-10-06 Dilorenzo Daniel J Cloosed-loop feedback-driven neuromodulation
US7209787B2 (en) * 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050021104A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050240242A1 (en) * 1998-08-05 2005-10-27 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US20070073355A1 (en) * 1998-08-05 2007-03-29 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050021103A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050119703A1 (en) * 1998-08-05 2005-06-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US6308098B1 (en) * 1998-09-08 2001-10-23 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Process for detection of physical position of a human being
US6044297A (en) * 1998-09-25 2000-03-28 Medtronic, Inc. Posture and device orientation and calibration for implantable medical devices
US6259948B1 (en) * 1998-11-13 2001-07-10 Pacesetter, Inc. Medical device
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6351672B1 (en) * 1999-07-22 2002-02-26 Pacesetter, Inc. System and method for modulating the pacing rate based on patient activity and position
US6449508B1 (en) * 1999-10-21 2002-09-10 Medtronic, Inc. Accelerometer count calculation for activity signal for an implantable medical device
US6466821B1 (en) * 1999-12-08 2002-10-15 Pacesetter, Inc. AC/DC multi-axis accelerometer for determining patient activity and body position
US20010031930A1 (en) * 1999-12-19 2001-10-18 Roizen Michael F. Alarm upon detection of impending sleep state
US6514218B2 (en) * 2000-01-07 2003-02-04 Minolta Co., Ltd. Posture detecting device and breathing function measuring device
US6611783B2 (en) * 2000-01-07 2003-08-26 Nocwatch, Inc. Attitude indicator and activity monitoring device
US20030139692A1 (en) * 2000-02-04 2003-07-24 Eric Barrey Method for analysing irregularities in human locomotion
US20030004423A1 (en) * 2000-03-02 2003-01-02 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US6884596B2 (en) * 2000-04-28 2005-04-26 The Regents Of The University Of California Screening and therapeutic methods for promoting wakefulness and sleep
US20010037067A1 (en) * 2000-05-09 2001-11-01 Patrick Tchou System and method for monitoring progression of cardiac disease state using physiologic sensors
US20040049132A1 (en) * 2000-06-15 2004-03-11 The Procter & Gamble Company Device for body activity detection and processing
US6605038B1 (en) * 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US6687538B1 (en) * 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
US6468234B1 (en) * 2000-07-14 2002-10-22 The Board Of Trustees Of The Leland Stanford Junior University SleepSmart
US6459934B1 (en) * 2000-07-21 2002-10-01 Cardiac Pacemakers, Inc. Estimate of efficiency using acceleration-heart rate ratio
US20040015103A1 (en) * 2000-10-05 2004-01-22 Kamiar Aminian Body movement monitoring system and method
US20020077562A1 (en) * 2000-12-15 2002-06-20 James Kalgren System and method for correlation of patient health information and implant device data
US20020091308A1 (en) * 2001-01-09 2002-07-11 Kipshidze Nicholas N. Method and apparatus for the synchronized therapeutic treatment of a life form
US6752766B2 (en) * 2001-01-30 2004-06-22 Peter Kowallik Method and device for sleep monitoring
US20020161412A1 (en) * 2001-04-25 2002-10-31 Cardiac Pacemakers, Inc. Determination of long-term condition of cardiac patients
US6731984B2 (en) * 2001-06-07 2004-05-04 Medtronic, Inc. Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same
US20030163059A1 (en) * 2001-12-07 2003-08-28 Yann Poezevera Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US6773404B2 (en) * 2001-12-07 2004-08-10 Ela Medical S.A. Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US6890306B2 (en) * 2001-12-14 2005-05-10 Ela Medical S.A. Active medical device for the diagnosis of the sleep apnea syndrome
US20050177192A1 (en) * 2002-02-01 2005-08-11 Ali Rezai Neurostimulation for affecting sleep disorders
US20030149457A1 (en) * 2002-02-05 2003-08-07 Neuropace, Inc. Responsive electrical stimulation for movement disorders
US20030153956A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Cardiac stimulation device including sleep apnea prevention and treatment
US20030153953A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Stimulation device for sleep apnea prevention, detection and treatment
US20030153955A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Cardiac stimulation device including sleep apnea prevention and treatment
US6928324B2 (en) * 2002-02-14 2005-08-09 Pacesetter, Inc. Stimulation device for sleep apnea prevention, detection and treatment
US20030171791A1 (en) * 2002-03-06 2003-09-11 Kenknight Bruce H. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US20030195588A1 (en) * 2002-04-16 2003-10-16 Neuropace, Inc. External ear canal interface for the treatment of neurological disorders
US6881192B1 (en) * 2002-06-12 2005-04-19 Pacesetter, Inc. Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
US20040002741A1 (en) * 2002-06-26 2004-01-01 Weinberg Lisa P. System and method for tracking progression of left ventricular dysfunction using implantable cardiac stimulation device
US20040002742A1 (en) * 2002-06-27 2004-01-01 Florio Joseph J. Using activity-based rest disturbance as a metric of sleep apnea
US6878121B2 (en) * 2002-11-01 2005-04-12 David T. Krausman Sleep scoring apparatus and method
US20040102814A1 (en) * 2002-11-22 2004-05-27 Chris Sorensen Physician programmer system with telemetered sensor waveform
US20040111041A1 (en) * 2002-12-04 2004-06-10 Quan Ni Sleep detection using an adjustable threshold
US20040111040A1 (en) * 2002-12-04 2004-06-10 Quan Ni Detection of disordered breathing
US7207947B2 (en) * 2003-01-10 2007-04-24 Pacesetter, Inc. System and method for detecting circadian states using an implantable medical device
US7162304B1 (en) * 2003-05-08 2007-01-09 Advanced Bionics Corporation System for measuring cardiac rhythm parameters for assessment of spinal cord stimulation
US20050042589A1 (en) * 2003-08-18 2005-02-24 Hatlestad John D. Sleep quality data collection and evaluation
US20050113710A1 (en) * 2003-09-18 2005-05-26 Stahmann Jeffrey E. Implantable device employing movement sensing for detecting sleep-related disorders
US20050085738A1 (en) * 2003-09-18 2005-04-21 Stahmann Jeffrey E. Sleep logbook
US20050240086A1 (en) * 2004-03-12 2005-10-27 Metin Akay Intelligent wearable monitor systems and methods
US20050215847A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Collecting sleep quality information via a medical device

Cited By (230)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10384024B2 (en) 2003-08-14 2019-08-20 New York University System and method for diagnosis and treatment of a breathing pattern of a patient
US9867955B2 (en) 2003-08-14 2018-01-16 New York University System and method for diagnosis and treatment of a breathing pattern of a patient
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
US10130815B2 (en) 2003-09-15 2018-11-20 Medtronic, Inc. Automatic therapy adjustments
US9138537B2 (en) 2003-10-02 2015-09-22 Medtronic, Inc. Determining catheter status
US10357620B2 (en) 2003-10-02 2019-07-23 Medtronic, Inc. Determining catheter status
US20110208163A1 (en) * 2003-10-02 2011-08-25 Medtronic, Inc. Pressure Sensing in Implantable Medical Devices
US7955319B2 (en) 2003-10-02 2011-06-07 Medtronic, Inc. Pressure sensing in implantable medical devices
US9033920B2 (en) 2003-10-02 2015-05-19 Medtronic, Inc. Determining catheter status
US20100069841A1 (en) * 2003-10-02 2010-03-18 Medtronic, Inc. Determining catheter status
US20080009837A1 (en) * 2003-10-02 2008-01-10 Medtronic, Inc. Pressure sensing in implantable medical devices
US9623248B2 (en) 2004-03-16 2017-04-18 Medtronic, Inc. Collecting sleep quality information via a medical device
US20100174155A1 (en) * 2004-03-16 2010-07-08 Medtronic, Inc. Collecting sleep quality information via a medical device
US8396554B2 (en) 2004-03-16 2013-03-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US20080071324A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US20080071326A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Detecting sleep to evaluate therapy
US20080071150A1 (en) * 2004-03-16 2008-03-20 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20080177355A1 (en) * 2004-03-16 2008-07-24 Medtronic, Inc. Collecting activity information to evaluate therapy
US8337431B2 (en) 2004-03-16 2012-12-25 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20050222522A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Detecting sleep
US8335568B2 (en) 2004-03-16 2012-12-18 Medtronic, Inc. Controlling therapy based on sleep quality
US20050222643A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Collecting activity information to evaluate therapy
US8332038B2 (en) 2004-03-16 2012-12-11 Medtronic, Inc. Detecting sleep to evaluate therapy
US8447401B2 (en) 2004-03-16 2013-05-21 Medtronic, Inc. Collecting posture information to evaluate therapy
US20050234514A1 (en) * 2004-03-16 2005-10-20 Heruth Kenneth T Collecting posture information to evaluate therapy
US20070123758A1 (en) * 2004-03-16 2007-05-31 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20090118599A1 (en) * 2004-03-16 2009-05-07 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US7542803B2 (en) 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US8190253B2 (en) 2004-03-16 2012-05-29 Medtronic, Inc. Collecting activity information to evaluate incontinence therapy
US8055348B2 (en) 2004-03-16 2011-11-08 Medtronic, Inc. Detecting sleep to evaluate therapy
US8308661B2 (en) 2004-03-16 2012-11-13 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20090306740A1 (en) * 2004-03-16 2009-12-10 Medtronic, Inc. Controlling therapy based on sleep quality
US7167743B2 (en) 2004-03-16 2007-01-23 Medtronic, Inc. Collecting activity information to evaluate therapy
US8725244B2 (en) 2004-03-16 2014-05-13 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20070276439A1 (en) * 2004-03-16 2007-11-29 Medtronic, Inc. Collecting sleep quality information via a medical device
US7775993B2 (en) 2004-03-16 2010-08-17 Medtronic, Inc. Detecting sleep
US7792583B2 (en) 2004-03-16 2010-09-07 Medtronic, Inc. Collecting posture information to evaluate therapy
US7805196B2 (en) 2004-03-16 2010-09-28 Medtronic, Inc. Collecting activity information to evaluate therapy
US20100305665A1 (en) * 2004-03-16 2010-12-02 Medtronic, Inc. Collecting posture information to evaluate therapy
US7881798B2 (en) 2004-03-16 2011-02-01 Medtronic Inc. Controlling therapy based on sleep quality
US8758242B2 (en) 2004-03-16 2014-06-24 Medtronic, Inc. Collecting sleep quality information via a medical device
US8792982B2 (en) 2004-03-16 2014-07-29 Medtronic, Inc. Collecting posture information to evaluate therapy
US7908013B2 (en) 2004-03-16 2011-03-15 Medtronic, Inc. Collecting activity information to evaluate therapy
US11096591B2 (en) 2004-03-16 2021-08-24 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20050215947A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Controlling therapy based on sleep quality
US8032224B2 (en) 2004-03-16 2011-10-04 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US10300283B2 (en) 2004-03-16 2019-05-28 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20050245988A1 (en) * 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8688221B2 (en) 2004-04-14 2014-04-01 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8135473B2 (en) 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20060009704A1 (en) * 2004-07-07 2006-01-12 Sanyo Electric Co., Ltd. Sleep state estimating device and program product
US7429247B2 (en) * 2004-07-07 2008-09-30 Sanyo Electric Co. Ltd. Sleep state estimating device and program product
US8021299B2 (en) 2005-06-01 2011-09-20 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US20070015976A1 (en) * 2005-06-01 2007-01-18 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US8016776B2 (en) 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
US10471264B2 (en) 2005-12-02 2019-11-12 Medtronic, Inc. Closed-loop therapy adjustment
US20070129622A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Wearable ambulatory data recorder
US8444578B2 (en) 2005-12-02 2013-05-21 Medtronic, Inc. Wearable ambulatory data recorder
US9592379B2 (en) 2006-03-24 2017-03-14 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US8744587B2 (en) 2006-03-24 2014-06-03 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US10251595B2 (en) 2006-03-24 2019-04-09 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US20070250134A1 (en) * 2006-03-24 2007-10-25 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US8317770B2 (en) 2006-04-06 2012-11-27 Medtronic, Inc. Systems and methods of identifying catheter malfunctions using pressure sensing
US20070270782A1 (en) * 2006-04-06 2007-11-22 Miesel Keith A Systems and methods of identifying catheter malfunctions using pressure sensing
US20110112381A1 (en) * 2007-02-09 2011-05-12 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US8369940B2 (en) 2007-02-09 2013-02-05 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US7894890B2 (en) * 2007-02-09 2011-02-22 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US9597032B2 (en) 2007-02-09 2017-03-21 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US9326724B2 (en) 2007-02-09 2016-05-03 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US8538514B2 (en) 2007-02-09 2013-09-17 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US20080195166A1 (en) * 2007-02-09 2008-08-14 Felice Sun Devices and methods for monitoring physiological information relating to sleep with an implantable device
US8068904B2 (en) 2007-02-09 2011-11-29 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US20080243074A1 (en) * 2007-03-30 2008-10-02 Miesel Keith A Catheter malfunction determinations using physiologic pressure
US9044537B2 (en) 2007-03-30 2015-06-02 Medtronic, Inc. Devices and methods for detecting catheter complications
US8323244B2 (en) 2007-03-30 2012-12-04 Medtronic, Inc. Catheter malfunction determinations using physiologic pressure
WO2009002238A1 (en) * 2007-06-27 2008-12-31 St. Jude Medical Ab A method and device for collecting rem sleep data
WO2009002237A1 (en) * 2007-06-27 2008-12-31 St. Jude Medical Ab A method and device for detecting rem sleep
US20100168812A1 (en) * 2007-06-27 2010-07-01 Andreas Blomqvist method and device for collecting rem sleep data
US20090082639A1 (en) * 2007-09-25 2009-03-26 Pittman Stephen D Automated Sleep Phenotyping
US9743841B2 (en) * 2007-09-25 2017-08-29 Ric Investments, Llc Automated sleep phenotyping
US8380314B2 (en) 2007-09-26 2013-02-19 Medtronic, Inc. Patient directed therapy control
US9248288B2 (en) 2007-09-26 2016-02-02 Medtronic, Inc. Patient directed therapy control
US20090082829A1 (en) * 2007-09-26 2009-03-26 Medtronic, Inc. Patient directed therapy control
US20090264789A1 (en) * 2007-09-26 2009-10-22 Medtronic, Inc. Therapy program selection
US10258798B2 (en) 2007-09-26 2019-04-16 Medtronic, Inc. Patient directed therapy control
US20090099627A1 (en) * 2007-10-16 2009-04-16 Medtronic, Inc. Therapy control based on a patient movement state
US8554325B2 (en) 2007-10-16 2013-10-08 Medtronic, Inc. Therapy control based on a patient movement state
US8121694B2 (en) 2007-10-16 2012-02-21 Medtronic, Inc. Therapy control based on a patient movement state
US10165977B2 (en) 2008-01-25 2019-01-01 Medtronic, Inc. Sleep stage detection
US9072870B2 (en) 2008-01-25 2015-07-07 Medtronic, Inc. Sleep stage detection
US20090192556A1 (en) * 2008-01-25 2009-07-30 Medtronic, Inc. Sleep stage detection
US9706957B2 (en) 2008-01-25 2017-07-18 Medtronic, Inc. Sleep stage detection
US9789252B2 (en) 2008-04-29 2017-10-17 Medtronic, Inc. Therapy program modification based on a therapy field model
US20110040547A1 (en) * 2008-04-29 2011-02-17 Gerber Martin T Therapy program modification based on therapy guidelines
WO2009134475A1 (en) 2008-04-29 2009-11-05 Medtronic, Inc. Therapy program modification based on a therapy field model
US8792991B2 (en) 2008-04-29 2014-07-29 Medtronic, Inc. Therapy program modification based on therapy guidelines
US10744260B2 (en) 2008-04-29 2020-08-18 Medtronic, Inc. Therapy program modification based on a therapy field model
US8200340B2 (en) 2008-07-11 2012-06-12 Medtronic, Inc. Guided programming for posture-state responsive therapy
US8332041B2 (en) 2008-07-11 2012-12-11 Medtronic, Inc. Patient interaction with posture-responsive therapy
US9956412B2 (en) 2008-07-11 2018-05-01 Medtronic, Inc. Linking posture states for posture responsive therapy
US8315710B2 (en) 2008-07-11 2012-11-20 Medtronic, Inc. Associating therapy adjustments with patient posture states
US8688225B2 (en) 2008-07-11 2014-04-01 Medtronic, Inc. Posture state detection using selectable system control parameters
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8282580B2 (en) 2008-07-11 2012-10-09 Medtronic, Inc. Data rejection for posture state analysis
US9919159B2 (en) 2008-07-11 2018-03-20 Medtronic, Inc. Programming posture responsive therapy
US8751011B2 (en) 2008-07-11 2014-06-10 Medtronic, Inc. Defining therapy parameter values for posture states
US8755901B2 (en) 2008-07-11 2014-06-17 Medtronic, Inc. Patient assignment of therapy parameter to posture state
US9968784B2 (en) 2008-07-11 2018-05-15 Medtronic, Inc. Posture state redefinition based on posture data
US8249718B2 (en) 2008-07-11 2012-08-21 Medtronic, Inc. Programming posture state-responsive therapy with nominal therapy parameters
US8231556B2 (en) 2008-07-11 2012-07-31 Medtronic, Inc. Obtaining baseline patient information
US8401666B2 (en) 2008-07-11 2013-03-19 Medtronic, Inc. Modification profiles for posture-responsive therapy
US8583252B2 (en) 2008-07-11 2013-11-12 Medtronic, Inc. Patient interaction with posture-responsive therapy
US9776008B2 (en) 2008-07-11 2017-10-03 Medtronic, Inc. Posture state responsive therapy delivery using dwell times
US8219206B2 (en) 2008-07-11 2012-07-10 Medtronic, Inc. Dwell time adjustments for posture state-responsive therapy
US8886302B2 (en) 2008-07-11 2014-11-11 Medtronic, Inc. Adjustment of posture-responsive therapy
US11004556B2 (en) 2008-07-11 2021-05-11 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8905948B2 (en) 2008-07-11 2014-12-09 Medtronic, Inc. Generation of proportional posture information over multiple time intervals
US10925517B2 (en) 2008-07-11 2021-02-23 Medtronic, Inc. Posture state redefinition based on posture data
US8958885B2 (en) 2008-07-11 2015-02-17 Medtronic, Inc. Posture state classification for a medical device
US8437861B2 (en) 2008-07-11 2013-05-07 Medtronic, Inc. Posture state redefinition based on posture data and therapy adjustments
US10207118B2 (en) 2008-07-11 2019-02-19 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8209028B2 (en) 2008-07-11 2012-06-26 Medtronic, Inc. Objectification of posture state-responsive therapy based on patient therapy adjustments
US8447411B2 (en) 2008-07-11 2013-05-21 Medtronic, Inc. Patient interaction with posture-responsive therapy
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
US11672989B2 (en) 2008-07-11 2023-06-13 Medtronic, Inc. Posture state responsive therapy delivery using dwell times
US10231650B2 (en) 2008-07-11 2019-03-19 Medtronic, Inc. Generation of sleep quality information based on posture state data
US8150531B2 (en) 2008-07-11 2012-04-03 Medtronic, Inc. Associating therapy adjustments with patient posture states
US9662045B2 (en) 2008-07-11 2017-05-30 Medtronic, Inc. Generation of sleep quality information based on posture state data
US8644945B2 (en) 2008-07-11 2014-02-04 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8326420B2 (en) 2008-07-11 2012-12-04 Medtronic, Inc. Associating therapy adjustments with posture states using stability timers
US8323218B2 (en) 2008-07-11 2012-12-04 Medtronic, Inc. Generation of proportional posture information over multiple time intervals
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US9592387B2 (en) 2008-07-11 2017-03-14 Medtronic, Inc. Patient-defined posture states for posture responsive therapy
US8515549B2 (en) 2008-07-11 2013-08-20 Medtronic, Inc. Associating therapy adjustments with intended patient posture states
US9272091B2 (en) 2008-07-11 2016-03-01 Medtronic, Inc. Posture state display on medical device user interface
US9560990B2 (en) 2008-07-11 2017-02-07 Medtronic, Inc. Obtaining baseline patient information
US9545518B2 (en) 2008-07-11 2017-01-17 Medtronic, Inc. Posture state classification for a medical device
US9327129B2 (en) 2008-07-11 2016-05-03 Medtronic, Inc. Blended posture state classification and therapy delivery
US9440084B2 (en) 2008-07-11 2016-09-13 Medtronic, Inc. Programming posture responsive therapy
US8515550B2 (en) 2008-07-11 2013-08-20 Medtronic, Inc. Assignment of therapy parameter to multiple posture states
US10271751B2 (en) * 2008-08-19 2019-04-30 Koninklijke Philips N.V. Monitoring the blood pressure of a patient
US20110144456A1 (en) * 2008-08-19 2011-06-16 Koninklijke Philips Electrnics N.V. Monitoring the blood pressure of a patient
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US8231555B2 (en) 2009-04-30 2012-07-31 Medtronic, Inc. Therapy system including multiple posture sensors
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
US9026223B2 (en) 2009-04-30 2015-05-05 Medtronic, Inc. Therapy system including multiple posture sensors
US10071197B2 (en) 2009-04-30 2018-09-11 Medtronic, Inc. Therapy system including multiple posture sensors
WO2011059948A1 (en) 2009-11-11 2011-05-19 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
US9770204B2 (en) 2009-11-11 2017-09-26 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
US20110112590A1 (en) * 2009-11-11 2011-05-12 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
US8758274B2 (en) 2010-01-08 2014-06-24 Medtronic, Inc. Automated adjustment of posture state definitions for a medical device
US9149210B2 (en) 2010-01-08 2015-10-06 Medtronic, Inc. Automated calibration of posture state classification for a medical device
US9174055B2 (en) 2010-01-08 2015-11-03 Medtronic, Inc. Display of detected patient posture state
US9956418B2 (en) 2010-01-08 2018-05-01 Medtronic, Inc. Graphical manipulation of posture zones for posture-responsive therapy
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US8388555B2 (en) 2010-01-08 2013-03-05 Medtronic, Inc. Posture state classification for a medical device
US20120330114A1 (en) * 2010-03-08 2012-12-27 Koninklijke Philips Electronics N.V. System and method for obtaining an objective measure of dyspnea
US9996677B2 (en) * 2010-03-08 2018-06-12 Koninklijke Philips N.V. System and method for obtaining an objective measure of dyspnea
US20130002417A1 (en) * 2010-03-11 2013-01-03 Toyota Jidosha Kabushiki Kaisha Biological state determination device
US8791825B2 (en) * 2010-03-11 2014-07-29 Toyota Jidosha Kabushiki Kaishi Biological state determination device
EP2546816A4 (en) * 2010-03-11 2018-05-02 Toyota Jidosha Kabushiki Kaisha Biological state determination device
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
WO2012027286A1 (en) 2010-08-26 2012-03-01 Medtronic, Inc. Therapy for rapid eye movement behavior disorder (rbd)
US9211411B2 (en) 2010-08-26 2015-12-15 Medtronic, Inc. Therapy for rapid eye movement behavior disorder (RBD)
US20140046153A1 (en) * 2010-12-16 2014-02-13 Stephen Frederick Woodford Monitoring volaemic condition in a human or animal subject
US8868173B2 (en) 2011-04-20 2014-10-21 Medtronic, Inc. Method and apparatus for assessing neural activation
US8914119B2 (en) 2011-04-20 2014-12-16 Medtronic, Inc. Electrical brain therapy parameter determination based on a bioelectrical resonance response
US8892207B2 (en) 2011-04-20 2014-11-18 Medtronic, Inc. Electrical therapy for facilitating inter-area brain synchronization
US9173609B2 (en) 2011-04-20 2015-11-03 Medtronic, Inc. Brain condition monitoring based on co-activation of neural networks
US8812098B2 (en) 2011-04-28 2014-08-19 Medtronic, Inc. Seizure probability metrics
US9878161B2 (en) 2011-04-29 2018-01-30 Medtronic, Inc. Entrainment of bioelectrical brain signals
US8583233B2 (en) * 2011-07-29 2013-11-12 Medtronic, Inc. Modification of AV conduction time sampling rate
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9396642B2 (en) 2013-10-23 2016-07-19 Quanttus, Inc. Control using connected biometric devices
US20150112158A1 (en) * 2013-10-23 2015-04-23 Quanttus, Inc. Health Metrics
US9396643B2 (en) 2013-10-23 2016-07-19 Quanttus, Inc. Biometric authentication
US9333351B2 (en) 2013-12-16 2016-05-10 Pacesetter, Inc. Neurostimulation method and system to treat apnea
WO2015104369A1 (en) * 2014-01-10 2015-07-16 Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) Systems for providing oxygen to a patient
WO2015164143A1 (en) 2014-04-25 2015-10-29 Medtronic, Inc. Deep brain stimulation for sleep disorders
US9821162B2 (en) 2014-04-25 2017-11-21 Medtronic, Inc. Deep brain stimulation for sleep disorders
US20190038185A1 (en) * 2014-09-23 2019-02-07 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US10772539B2 (en) * 2014-09-23 2020-09-15 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US20210059571A1 (en) * 2014-09-23 2021-03-04 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US9675281B2 (en) 2014-09-23 2017-06-13 Fitbit, Inc. Automatic change of power consumption of sensors responsive to user's state transition
US10092219B2 (en) * 2014-09-23 2018-10-09 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US11717188B2 (en) * 2014-09-23 2023-08-08 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US9808185B2 (en) 2014-09-23 2017-11-07 Fitbit, Inc. Movement measure generation in a wearable electronic device
US20160022203A1 (en) * 2014-09-23 2016-01-28 Fitbit, Inc. Automatic detection of user's periods of sleep and sleep stage
US11109805B1 (en) 2015-02-17 2021-09-07 Tula Health, Inc. Power management for wearable devices
US11857337B1 (en) 2015-02-17 2024-01-02 Tula Health, Inc. Power management for wearable devices
US10765320B1 (en) 2015-02-17 2020-09-08 Tula Health, Inc. Baselining user profiles from portable device information
US10806398B2 (en) 2015-02-17 2020-10-20 Halo Wearables, Llc Power management for wearable devices
US10368744B1 (en) * 2015-02-17 2019-08-06 Halo Wearables, Llc Baselining user profiles from portable device information
US11872009B1 (en) 2015-02-17 2024-01-16 Tula Health, Inc. Baselining user profiles from portable device information
US10729352B2 (en) 2015-08-17 2020-08-04 Neuropace, Inc. Neurological event detection tools for implantable medical devices
US11642077B2 (en) 2016-04-29 2023-05-09 Fitbit, Inc. Sleep monitoring system with optional alarm functionality
US10311745B2 (en) 2016-06-02 2019-06-04 Fitbit, Inc. Systems and techniques for tracking sleep consistency and sleep goals
US10325514B2 (en) 2016-06-02 2019-06-18 Fitbit, Inc. Systems and techniques for tracking sleep consistency and sleep goals
US11626031B2 (en) 2016-06-02 2023-04-11 Fitbit, Inc. Systems and techniques for tracking sleep consistency and sleep goals
US11219408B2 (en) * 2016-08-25 2022-01-11 Night Train Oy Method and system for determining time window for sleep of a person
US11207021B2 (en) 2016-09-06 2021-12-28 Fitbit, Inc Methods and systems for labeling sleep states
US11877861B2 (en) 2016-09-06 2024-01-23 Fitbit, Inc. Methods and systems for labeling sleep states
US10111615B2 (en) 2017-03-11 2018-10-30 Fitbit, Inc. Sleep scoring based on physiological information
US10555698B2 (en) 2017-03-11 2020-02-11 Fitbit, Inc. Sleep scoring based on physiological information
US11864723B2 (en) 2017-03-11 2024-01-09 Fitbit, Inc. Sleep scoring based on physiological information
US10980471B2 (en) 2017-03-11 2021-04-20 Fitbit, Inc. Sleep scoring based on physiological information
US11596795B2 (en) 2017-07-31 2023-03-07 Medtronic, Inc. Therapeutic electrical stimulation therapy for patient gait freeze
CN107595245A (en) * 2017-08-15 2018-01-19 深圳创达云睿智能科技有限公司 A kind of dormancy management method, system and terminal device
WO2019033787A1 (en) * 2017-08-15 2019-02-21 深圳创达云睿智能科技有限公司 Sleep management method and system, and terminal device
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11647945B2 (en) * 2017-12-07 2023-05-16 Paramount Bed Co., Ltd. Evaluating apparatus and non-transitory computer readable medium storing program
US20190175103A1 (en) * 2017-12-07 2019-06-13 Paramount Bed Co., Ltd. Evaluating apparatus and non-transitory computer readable medium storing program
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11273283B2 (en) 2017-12-31 2022-03-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US20230095780A1 (en) * 2019-07-25 2023-03-30 Inspire Medical Systems, Inc. Sleep detection for sleep disordered breathing (sdb) care
JPWO2022038710A1 (en) * 2020-08-19 2022-02-24
JP7420264B2 (en) 2020-08-19 2024-01-23 日本電信電話株式会社 Monitoring method, monitoring program and monitoring device
WO2022038710A1 (en) * 2020-08-19 2022-02-24 日本電信電話株式会社 Watching method, watching program, and watching device
US11642531B2 (en) 2020-10-09 2023-05-09 Medtronic, Inc. Sensing cardiac signals with leads implanted in epidural space
US11856257B2 (en) 2021-08-31 2023-12-26 Rovi Guides, Inc. Measuring sleep state of a user using wearables and deciding on the playback option for the content consumed
US11483619B1 (en) 2021-08-31 2022-10-25 Rovi Guides, Inc. Measuring sleep state of a user using wearables and deciding on the playback option for the content consumed
CN114259210A (en) * 2021-12-27 2022-04-01 上海交通大学 Sleep staging method and control system based on dynamic skin temperature
WO2023241469A1 (en) * 2022-06-13 2023-12-21 华为技术有限公司 Sleep monitoring method and device

Also Published As

Publication number Publication date
DE602005020758D1 (en) 2010-06-02
ATE464836T1 (en) 2010-05-15
US7775993B2 (en) 2010-08-17
EP1732436B1 (en) 2010-04-21
EP1732436A1 (en) 2006-12-20
US20050222522A1 (en) 2005-10-06
US20100274106A1 (en) 2010-10-28
WO2005089641A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
US7775993B2 (en) Detecting sleep
US9623248B2 (en) Collecting sleep quality information via a medical device
US7366572B2 (en) Controlling therapy based on sleep quality
US8055348B2 (en) Detecting sleep to evaluate therapy
US8337431B2 (en) Collecting activity and sleep quality information via a medical device
US7447545B2 (en) Collecting posture information to evaluate therapy
US7881798B2 (en) Controlling therapy based on sleep quality
US8308661B2 (en) Collecting activity and sleep quality information via a medical device
US7542803B2 (en) Sensitivity analysis for selecting therapy parameter sets
US7908013B2 (en) Collecting activity information to evaluate therapy
US20070276439A1 (en) Collecting sleep quality information via a medical device

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HERUTH, KENNETH T.;MIESEL, KEITH A.;REEL/FRAME:015720/0033

Effective date: 20040701

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION